Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2010);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;12.86;Q1;210;17;66;2944;1683;66;21;173.18;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;8.749;Q1;241;22;53;9201;1072;52;19.54;418.23;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;6.569;Q1;348;242;519;7490;5949;413;10.38;30.95;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;4700152457;Nano Today;journal;17480132;5.824;Q1;155;63;112;3753;1086;83;9.23;59.57;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;5.544;Q1;225;80;261;5902;3048;247;11.79;73.78;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;12611;Drug Resistance Updates;journal;13687646, 15322084;5.328;Q1;119;19;49;2423;642;49;13.41;127.53;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;4.742;Q1;331;127;396;15651;5652;347;13.76;123.24;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
8;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;4.001;Q1;233;303;885;27854;6267;874;7.26;91.93;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
9;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;3.872;Q1;211;103;308;22992;3279;305;9.9;223.22;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
10;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;3.368;Q1;227;249;806;16794;5508;780;6.81;67.45;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
11;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;3.365;Q1;139;112;323;5804;2365;294;6.99;51.82;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
12;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;3.236;Q1;66;0;12;0;109;12;11.8;0;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
13;23010;Journal of Controlled Release;journal;18734995, 01683659;3.225;Q1;282;482;844;16584;6547;793;7.3;34.41;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
14;12455;Molecular Therapy;journal;15250024, 15250016;3.038;Q1;185;268;803;10279;5002;707;6.46;38.35;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;26371;Natural Product Reports;journal;02650568, 14604752;3.02;Q1;188;83;210;13863;1690;201;7.76;167.02;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
16;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;2.974;Q1;43;20;59;72;353;58;7.57;3.6;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
17;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.961;Q1;134;25;88;4452;877;87;10.1;178.08;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
18;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.831;Q1;190;173;475;6762;2279;432;4.58;39.09;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
19;18148;Pain;journal;18726623, 03043959;2.688;Q1;269;380;1095;15128;6061;849;5.05;39.81;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
20;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.611;Q1;146;138;409;6211;2084;387;5.01;45.01;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
21;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.463;Q1;202;222;983;9195;5024;979;5.16;41.42;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
22;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.458;Q1;269;858;2377;27623;12225;2242;4.98;32.19;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
23;20435;Neuropharmacology;journal;00283908, 18737064;2.355;Q1;176;225;821;12830;3979;813;5.1;57.02;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
24;5100155080;Neurotherapeutics;journal;19337213;2.32;Q1;122;53;220;4993;1463;206;6.79;94.21;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
25;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;2.295;Q1;195;278;782;6612;4265;652;5.15;23.78;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
26;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2.273;Q1;177;288;891;11639;4778;886;5.32;40.41;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
27;130126;Molecular Pharmaceutics;journal;15438384, 15438392;2.252;Q1;138;221;395;9892;2530;380;5.86;44.76;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
28;29311;Current Cancer Drug Targets;journal;15680096, 18735576;2.236;Q1;96;86;225;5566;1106;214;4.88;64.72;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
29;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;2.189;Q1;115;127;443;9032;2186;438;4.57;71.12;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
30;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.161;Q1;203;419;1656;10729;7073;1289;4.24;25.61;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
31;21782;Psychopharmacology;journal;00333158, 14322072;2.125;Q1;202;274;1086;14738;4803;1048;4.02;53.79;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
32;4400151524;Particle and Fibre Toxicology;journal;17438977;2.097;Q1;105;41;64;2370;423;60;5.6;57.8;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
33;21196;Drug Discovery Today;journal;18785832, 13596446;2.028;Q1;185;140;452;8078;3117;428;6.54;57.7;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
34;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.014;Q1;276;757;2404;37025;12862;2400;5.42;48.91;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
35;23916;Environmental Pollution;journal;02697491, 18736424;2.002;Q1;249;475;1453;21905;5952;1432;3.68;46.12;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
36;26380;Drug and Alcohol Dependence;journal;03768716;1.976;Q1;173;258;778;11526;3250;748;3.66;44.67;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
37;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.966;Q1;223;498;1547;26328;7570;1480;4.73;52.87;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
38;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.961;Q1;168;185;714;7092;3725;706;4.93;38.34;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
39;24749;Addiction Biology;journal;13556215, 13691600;1.932;Q1;83;45;137;3242;639;133;4.49;72.04;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
40;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.925;Q1;213;252;788;12006;4210;758;4.89;47.64;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Molecular Medicine (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
41;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.892;Q1;113;125;335;6482;1453;309;4.09;51.86;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
42;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.889;Q1;206;417;1092;23697;5526;997;5.11;56.83;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
43;25218;Toxicological Sciences;journal;10960929, 10966080;1.874;Q1;193;262;908;12241;4622;854;4.82;46.72;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
44;21790;Antiviral Therapy;journal;20402058, 13596535;1.852;Q1;89;147;426;5522;1715;418;3.65;37.56;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
45;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.846;Q1;90;86;147;10049;656;130;3.64;116.85;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
46;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.826;Q1;96;87;364;8617;1517;339;4.35;99.05;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
47;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.807;Q1;233;439;1495;16569;6808;1483;4.41;37.74;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
48;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;1.795;Q1;143;350;445;15673;2072;407;4.65;44.78;United States;Northern America;Public Library of Science;2007-2021;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
49;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.784;Q1;97;99;283;4322;1121;281;3.78;43.66;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2)"
50;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.775;Q1;96;73;219;2352;661;207;3.21;32.22;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
51;16088;Journal of Nanobiotechnology;journal;14773155;1.77;Q1;84;34;35;1349;250;33;5.25;39.68;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
52;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.768;Q1;133;92;138;3602;924;134;5.64;39.15;United States;Northern America;Elsevier Inc.;2005-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
53;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.7;Q1;183;289;800;38208;4310;799;5.24;132.21;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
54;20104;CNS Drug Reviews;journal;1080563X, 15273458;1.699;Q1;61;0;26;0;152;26;0;0;United States;Northern America;Neva Press, Inc.;1995-2007;"Pharmacology (Q1); Neuropsychology and Physiological Psychology (Q2)"
55;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.692;Q1;118;95;332;5527;1460;326;4.43;58.18;Netherlands;Western Europe;Elsevier;1990-2021;"Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
56;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;1.673;Q1;50;0;25;0;133;24;0;0;United States;Northern America;Neva Press, Inc.;1983-2007;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
57;22072;Current Gene Therapy;journal;18755631, 15665232;1.672;Q1;75;47;127;4735;650;123;4.95;100.74;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q1); Molecular Medicine (Q1); Genetics (clinical) (Q2); Molecular Biology (Q2)"
58;20051;BioDrugs;journal;11738804, 1179190X;1.664;Q1;71;47;119;2941;571;111;5.33;62.57;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
59;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.661;Q1;81;68;221;4845;1122;204;5.31;71.25;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
60;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.661;Q1;90;51;140;2259;750;137;4.85;44.29;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Genetics (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
61;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.657;Q1;166;409;1056;45111;4974;943;4.82;110.3;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
62;21237;Drug Safety;journal;01145916, 11791942;1.62;Q1;131;103;311;4330;1283;259;4;42.04;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
63;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.594;Q1;94;109;377;11083;1497;363;3.93;101.68;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
64;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.577;Q1;175;286;980;15088;4417;957;4.33;52.76;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
65;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.574;Q1;229;642;1709;22432;7426;1692;4.14;34.94;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
66;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.568;Q1;159;253;745;13213;2824;732;3.62;52.23;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
67;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.552;Q1;76;11;38;1827;176;38;3.84;166.09;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
68;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.546;Q1;117;43;114;5878;610;106;4.76;136.7;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
69;84948;Expert Opinion on Drug Delivery;journal;17425247;1.546;Q1;116;97;253;9623;1280;242;5.1;99.21;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
70;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.537;Q1;163;215;724;10210;3199;694;4.61;47.49;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
71;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.533;Q1;169;58;190;4333;1013;177;5.29;74.71;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
72;26512;Tetrahedron;journal;14645416, 00404020;1.526;Q1;226;1187;3955;59908;12586;3927;3.08;50.47;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
73;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.508;Q1;182;289;920;9178;4036;918;4.19;31.76;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
74;144771;Clinical Trials;journal;17407753, 17407745;1.507;Q1;67;76;188;1771;401;153;2.13;23.3;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
75;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;1.502;Q1;121;165;443;3971;1740;422;3.97;24.07;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
76;5400152706;Nanotoxicology;journal;17435390, 17435404;1.501;Q1;94;32;85;1602;428;82;3.54;50.06;United Kingdom;Western Europe;Informa Healthcare;2007-2021;"Biomedical Engineering (Q1); Toxicology (Q1); Nanoscience and Nanotechnology (Q2)"
77;4000148019;AAPS Journal;journal;15507416;1.494;Q1;118;82;189;3723;981;185;4.09;45.4;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q1)
78;20783;Expert Review of Vaccines;journal;14760584, 17448395;1.482;Q1;91;142;390;10509;1518;333;3.86;74.01;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q1); Pharmacology (Q1); Immunology (Q2); Molecular Medicine (Q2)"
79;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.479;-;144;96;347;4069;1625;342;4.28;42.39;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
80;21169;Pharmacological Research;journal;10436618, 10961186;1.479;Q1;147;133;374;8179;1774;361;4.1;61.5;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q1)
81;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;1.447;Q1;145;115;132;4368;719;129;6;37.98;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Nanoscience and Nanotechnology (Q2)"
82;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.438;Q1;89;27;70;2257;338;66;4.79;83.59;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
83;24763;Addictive Behaviors;journal;03064603;1.429;Q1;135;200;663;7546;1898;662;2.42;37.73;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
84;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;1.423;Q1;186;436;1074;17118;4026;1036;3.56;39.26;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
85;19617;Antiviral Research;journal;01663542, 18729096;1.409;Q1;134;190;383;11217;1668;383;4.72;59.04;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
86;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;1.399;Q1;122;138;497;13860;1870;424;3.65;100.43;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
87;25075;Ecotoxicology;journal;09639292, 15733017;1.38;Q1;97;160;277;8344;889;275;3.19;52.15;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
88;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.371;Q1;100;39;93;4582;466;88;4.54;117.49;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
89;23053;Journal of Natural Products;journal;01633864, 15206025;1.37;Q1;147;392;1254;11108;4181;1232;3.1;28.34;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
90;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.367;Q1;109;149;508;11809;2152;487;4.38;79.26;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
91;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.359;Q1;83;81;250;5428;723;247;2.63;67.01;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
92;20664;Current Drug Targets;journal;18735592, 13894501;1.356;Q1;107;159;397;17091;1361;355;3.06;107.49;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
93;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.354;Q1;100;86;228;7351;983;208;4;85.48;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
94;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.351;Q1;121;231;378;9785;1306;326;3.14;42.36;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
95;145164;Human Genomics;journal;14739542, 14797364;1.348;Q1;59;36;53;834;121;43;2.28;23.17;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
96;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.344;Q1;77;55;126;4586;436;119;3.45;83.38;United States;Northern America;Springer New York;2006-2021;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2); Neuroscience (miscellaneous) (Q2)"
97;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.336;Q1;66;88;220;5913;798;203;3.86;67.19;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
98;24028;Reproductive Toxicology;journal;08906238, 18731708;1.334;Q1;117;137;348;6145;1504;328;3.38;44.85;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q1)
99;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.32;Q1;139;226;696;12373;2181;692;2.9;54.75;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
100;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.317;Q1;134;301;909;11901;2746;724;2.92;39.54;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
101;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.313;Q1;95;58;165;3134;516;165;2.82;54.03;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
102;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.31;Q1;120;329;1025;12767;2458;790;2.31;38.81;United States;Northern America;Landes Bioscience;2002-2021;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
103;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.309;Q1;129;114;330;4541;876;329;2.25;39.83;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
104;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;1.298;Q1;88;105;195;7390;672;177;3.47;70.38;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Biotechnology (Q1); Pharmaceutical Science (Q1)"
105;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;1.295;Q1;144;187;437;7133;1575;429;3.66;38.14;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
106;4400151608;ChemMedChem;journal;18607187, 18607179;1.294;Q1;106;211;603;9609;2140;592;3.38;45.54;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
107;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.29;Q1;70;37;108;1291;320;107;3.12;34.89;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
108;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.289;Q1;71;54;198;2365;531;157;2.68;43.8;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
109;21167;Pharmacogenomics;journal;14622416, 17448042;1.281;Q1;94;190;537;7298;1953;454;3.59;38.41;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
110;14990;Current Neuropharmacology;journal;18756190, 1570159X;1.271;Q1;82;41;88;4630;323;85;3.44;112.93;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2)"
111;22477;Investigational New Drugs;journal;01676997, 15730646;1.265;Q1;90;108;211;3933;661;211;2.84;36.42;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
112;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;1.257;Q1;79;144;375;10224;1326;340;3.69;71;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
113;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.256;Q1;91;147;477;12860;1735;468;3.69;87.48;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
114;21165;PharmacoEconomics;journal;11707690, 11792027;1.253;Q1;104;110;259;4458;815;206;3.38;40.53;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
115;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.25;Q1;39;33;88;559;151;82;1.49;16.94;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
116;20663;Current Drug Metabolism;journal;18755453, 13892002;1.247;Q1;111;73;280;7949;1365;265;4.57;108.89;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
117;18966;Mutagenesis;journal;02678357, 14643804;1.246;Q1;95;78;179;3437;736;173;4.23;44.06;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
118;26514;Tetrahedron Letters;journal;00404039, 18733581;1.245;Q1;173;1731;5607;58964;15142;5606;2.68;34.06;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
119;25240;Toxicology Letters;journal;03784274, 18793169;1.233;Q1;150;304;682;12512;2557;658;3.5;41.16;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
120;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.219;Q1;114;251;754;7861;2297;739;3.01;31.32;Germany;Western Europe;Springer Verlag;1978-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2)"
121;25219;Toxicology;journal;0300483X, 18793185;1.218;Q1;165;221;828;11253;3103;804;3.77;50.92;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
122;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.194;Q1;153;202;734;5994;2279;550;3.03;29.67;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
123;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;1.193;Q1;205;529;1378;19441;4944;1370;3.1;36.75;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q1); Pharmacology (Q1)"
124;4700152848;PPAR Research;journal;16874757, 16874765;1.176;Q1;52;59;196;4684;536;183;2.54;79.39;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Drug Discovery (Q1); Pharmacology (medical) (Q1)"
125;25109;Inhalation Toxicology;journal;08958378, 10917691;1.174;Q1;90;137;411;6007;1198;389;2.25;43.85;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
126;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;1.174;Q1;104;85;215;3775;811;206;3.49;44.41;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q1)"
127;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;1.173;Q1;104;175;456;7866;1413;439;2.73;44.95;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
128;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;1.156;Q1;46;20;72;2718;221;72;3.12;135.9;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)"
129;23014;Journal of Drug Targeting;journal;10292330, 1061186X;1.152;Q1;95;83;247;3686;828;238;2.71;44.41;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
130;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.146;Q1;76;49;169;2791;472;166;2.27;56.96;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
131;18071;Neurotoxicity Research;journal;14763524, 10298428;1.13;Q1;78;69;179;3720;514;175;2.86;53.91;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
132;18073;NeuroToxicology;journal;18729711, 0161813X;1.128;Q1;122;98;472;4813;1529;449;3.05;49.11;Netherlands;Western Europe;Elsevier;1979-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
133;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;1.118;Q1;133;473;1402;12905;4398;1396;3.04;27.28;Netherlands;Western Europe;Elsevier;1983-2022;"Analytical Chemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q2)"
134;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;1.117;Q1;78;56;122;2143;435;109;3.1;38.27;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q2)"
135;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;1.087;Q1;66;65;324;1766;666;208;1.9;27.17;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
136;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.083;Q1;171;891;2601;33501;8605;2595;3.14;37.6;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
137;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1.08;Q1;154;1586;4100;41450;11606;4098;2.83;26.13;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
138;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.068;Q1;140;249;856;7473;2862;775;2.88;30.01;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
139;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;1.064;Q1;52;85;246;1783;353;224;1.12;20.98;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
140;17067;Phytomedicine;journal;09447113, 1618095X;1.062;Q1;127;194;456;6109;1540;447;3.1;31.49;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
141;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.06;Q1;114;183;501;5329;1514;427;3.11;29.12;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
142;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.054;Q1;72;48;138;1544;307;138;2.29;32.17;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Immunology (Q2); Microbiology (Q2); Microbiology (medical) (Q2)"
143;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;1.054;Q1;93;101;328;4316;919;327;2.76;42.73;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
144;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.043;Q2;189;686;2230;29037;6820;2226;3.1;42.33;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q2)
145;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;1.043;Q1;88;121;315;10240;1245;310;3.81;84.63;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1); Pharmacology (Q2)"
146;23155;Current Vascular Pharmacology;journal;15701611, 18756212;1.04;Q2;63;87;128;9547;455;119;3.65;109.74;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
147;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;1.028;Q1;113;124;421;6254;1215;416;2.55;50.44;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1); Biochemistry (Q2); Physiology (Q2); Cell Biology (Q3)"
148;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.018;Q1;103;75;323;2810;915;302;2.72;37.47;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
149;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;1.017;Q1;79;132;320;3470;865;318;2.8;26.29;United States;Northern America;SAGE Publications Inc.;1996-2017;"Drug Discovery (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
150;19427;Advances in Pharmacology;journal;15578925, 10543589;1.013;Q2;78;42;45;4899;107;38;1.52;116.64;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
151;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.013;Q2;75;52;66;4399;258;63;3.91;84.6;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Pharmacology (Q2); Physiology (medical) (Q2)"
152;20473;Life Sciences;journal;18790631, 00243205;1.009;Q1;174;228;1034;11111;3100;1033;2.73;48.73;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
153;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;1.008;Q2;87;183;585;6327;1531;580;2.53;34.57;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
154;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;1.004;Q2;51;43;116;4170;407;113;3.5;96.98;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2015;"Medicine (miscellaneous) (Q1); Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
155;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.999;Q2;115;178;475;7655;1082;475;2.16;43.01;United States;Northern America;Springer New York;1973-2021;"Medicine (miscellaneous) (Q1); Pollution (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
156;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;0.996;Q2;48;59;69;3319;170;63;2.46;56.25;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
157;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.995;Q2;103;76;158;4273;498;156;2.78;56.22;United States;Northern America;Elsevier Inc.;1987-2021;"Developmental Neuroscience (Q2); Toxicology (Q2); Cellular and Molecular Neuroscience (Q3)"
158;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.991;Q1;94;98;334;3755;1118;329;3.13;38.32;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Medicine (Q2); Genetics (clinical) (Q3); Molecular Biology (Q3)"
159;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.984;Q2;51;47;133;4968;468;133;3.89;105.7;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
160;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.966;Q2;58;119;271;1960;426;144;1.48;16.47;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q2); Molecular Medicine (Q2)"
161;24652;Chemico-Biological Interactions;journal;00092797;0.959;Q2;128;364;657;15798;2170;648;3.19;43.4;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
162;130047;Current Drug Discovery Technologies;journal;15701638;0.956;Q2;44;29;93;2418;295;90;3.5;83.38;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q2)
163;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.941;Q2;102;0;167;0;492;165;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
164;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.94;Q2;90;88;306;3386;644;305;2.09;38.48;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Computational Theory and Mathematics (Q2); Immunology (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2)"
165;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.939;Q2;92;161;601;6216;1245;590;1.84;38.61;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
166;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.939;Q2;95;107;402;10462;1267;401;2.93;97.78;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
167;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.93;Q2;183;565;1403;22531;4313;1378;3.06;39.88;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
168;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.93;Q2;39;21;59;418;95;55;2.13;19.9;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q2)"
169;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.926;Q2;112;152;385;6455;1053;345;2.57;42.47;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
170;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.923;Q2;52;55;101;2371;270;99;2.58;43.11;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
171;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.919;Q2;56;33;85;1290;223;84;1.9;39.09;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
172;25214;Toxicologic Pathology;journal;15331601, 01926233;0.915;Q2;112;116;346;4556;925;322;2.17;39.28;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
173;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.913;Q2;96;123;413;5062;1034;408;2.5;41.15;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
174;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.91;Q1;69;75;196;2601;536;176;2.65;34.68;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
175;16948;Chirality;journal;1520636X, 08990042;0.904;Q2;80;142;387;4819;960;381;2.48;33.94;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
176;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.896;Q2;64;35;104;1236;190;103;1.84;35.31;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
177;24604;Archives of Toxicology;journal;14320738, 03405761;0.895;Q2;121;91;328;6069;977;296;3.17;66.69;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
178;22432;International Immunopharmacology;journal;18781705, 15675769;0.893;Q2;119;230;687;8900;1934;678;2.64;38.7;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
179;16836;BMC Chemical Biology;journal;14726769;0.889;Q2;20;7;12;306;26;12;2.4;43.71;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q2); Molecular Medicine (Q2)"
180;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;0.887;Q2;175;764;1104;27203;4101;1104;3.53;35.61;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
181;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.887;Q2;96;129;333;4198;1065;325;3.41;32.54;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
182;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.886;Q2;34;22;64;2758;189;64;2.86;125.36;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2016;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
183;14822;Xenobiotica;journal;00498254, 13665928;0.881;Q2;82;86;281;2861;834;276;3.06;33.27;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2)"
184;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.876;Q2;55;44;122;3794;307;107;2.25;86.23;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
185;22319;Toxicon;journal;18793150, 00410101;0.872;Q2;133;358;762;16668;2095;751;2.5;46.56;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
186;29053;Molecular Diversity;journal;1573501X, 13811991;0.87;Q2;58;88;90;3395;277;86;3.38;38.58;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Information Systems (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
187;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.869;Q2;81;92;635;4036;1363;621;2.13;43.87;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
188;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.858;Q2;32;23;80;1543;200;76;2.29;67.09;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
189;4400151410;Human Vaccines;journal;15548600, 15548619;0.857;Q1;58;184;283;7231;591;228;2.15;39.3;United States;Northern America;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q3)"
190;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.842;Q2;40;20;100;1852;268;99;2.86;92.6;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2)"
191;25224;Toxicology in Vitro;journal;18793177, 08872333;0.836;Q2;112;271;664;10929;1884;654;2.84;40.33;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
192;4000150314;Chemical Biology and Drug Design;journal;17470277;0.832;-;82;127;383;4924;977;375;2.58;38.77;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q2); Molecular Medicine (Q2)"
193;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.832;Q2;107;212;705;8737;1594;675;2.07;41.21;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
194;22378;Vascular Pharmacology;journal;18793649, 15371891;0.827;Q2;100;68;239;3663;614;237;2.36;53.87;United States;Northern America;Elsevier Inc.;2002-2021;"Molecular Medicine (Q2); Pharmacology (Q2); Physiology (Q2)"
195;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.822;Q2;66;99;271;5804;675;243;2.62;58.63;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2)"
196;24785;Alcohol;journal;07418329;0.819;Q2;83;74;195;4078;496;191;2.59;55.11;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
197;130063;Pharmacological Reports;journal;17341140;0.817;Q2;87;146;367;5766;995;365;2.88;39.49;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
198;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.816;Q2;80;179;354;6008;872;348;2.46;33.56;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
199;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.798;Q2;99;395;1293;5827;1863;816;1.41;14.75;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
200;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.793;Q2;64;46;147;2657;398;146;2.62;57.76;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
201;21744;Planta Medica;journal;14390221, 00320943;0.778;Q1;122;299;726;9544;1763;718;2.36;31.92;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
202;25093;Environmental Toxicology;journal;15227278, 15204081;0.769;Q2;81;71;238;2945;483;238;1.88;41.48;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
203;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;0.769;Q2;36;6;27;624;45;21;1.59;104;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q2); Molecular Medicine (Q3)"
204;25898;Journal of Peptide Science;journal;10752617, 10991387;0.764;Q2;68;101;376;3649;715;367;1.93;36.13;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
205;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;0.761;Q2;78;90;325;2289;545;300;1.49;25.43;United States;Northern America;Preston Publications;1977-2021;"Chemical Health and Safety (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
206;19374;AAPS PharmSciTech;journal;15309932;0.754;Q1;101;199;461;6282;1026;458;1.54;31.57;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
207;144790;Marine Drugs;journal;16603397;0.751;Q2;128;154;103;11747;390;102;3.71;76.28;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q2)
208;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.746;Q1;31;20;70;509;112;59;1.65;25.45;United States;Northern America;Springer New York;2006-2021;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
209;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.744;Q1;122;364;1290;11246;2833;1286;2.05;30.9;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
210;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.74;Q2;91;93;286;4305;719;281;2.5;46.29;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
211;16573;Phytotherapy Research;journal;10991573, 0951418X;0.735;Q2;140;335;815;9777;2094;814;2.26;29.19;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
212;5800173383;Current Clinical Pharmacology;journal;15748847, 22123938;0.732;Q1;0;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers;2006-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
213;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.728;Q2;109;126;330;4042;858;320;2.5;32.08;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
214;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.725;Q2;47;43;114;1711;298;109;2.96;39.79;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
215;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.724;Q2;93;141;434;5065;1126;428;2.66;35.92;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
216;22411;Inflammopharmacology;journal;09254692, 15685608;0.723;Q2;55;30;125;1103;309;123;3.28;36.77;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
217;16067;Reading Teacher;journal;00340561;0.721;Q2;53;85;244;1516;199;242;0.79;17.84;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
218;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.718;Q2;64;94;241;2599;518;232;2.08;27.65;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
219;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.715;Q2;87;148;385;5885;789;376;2.02;39.76;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
220;14805;Steroids;journal;0039128X, 18785867;0.715;Q2;107;153;427;6495;1419;423;3.25;42.45;United States;Northern America;Elsevier Inc.;1963-2021;"Clinical Biochemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Endocrinology (Q3); Molecular Biology (Q3)"
221;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.71;Q2;52;57;119;2873;291;108;2.35;50.4;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
222;23942;Biomedical Chromatography;journal;10990801, 02693879;0.709;Q2;68;186;540;4524;950;528;1.57;24.32;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
223;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.705;Q2;42;34;95;3265;207;93;1.97;96.03;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
224;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.704;Q2;90;160;470;5601;819;467;1.6;35.01;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
225;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.699;Q2;38;17;71;546;138;70;2.15;32.12;United States;Northern America;Old City Publishing;1996, 2002-2020;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
226;19600166302;Current Molecular Pharmacology;journal;18744702;0.69;Q2;42;14;50;1728;117;50;2.34;123.43;United Arab Emirates;Middle East;Bentham Science Publishers;2008-2021;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
227;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.687;Q2;77;118;324;9662;666;316;2.63;81.88;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
228;20026;BMC Clinical Pharmacology;journal;14726904;0.679;Q2;39;16;45;462;141;45;2.48;28.88;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
229;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.677;Q2;88;92;355;4087;622;353;1.57;44.42;Netherlands;Western Europe;Elsevier;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
230;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.674;Q2;98;161;494;3863;847;400;1.65;23.99;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
231;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.673;Q2;66;45;112;1592;216;111;1.57;35.38;United States;Northern America;Academic Press Inc.;1971-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
232;130025;Current Drug Delivery;journal;15672018;0.673;Q1;65;51;144;1910;393;143;1.81;37.45;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q1)
233;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.668;Q2;63;93;266;2971;494;260;2.2;31.95;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
234;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.667;Q2;98;210;639;8634;1294;636;1.95;41.11;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
235;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.666;Q1;65;35;123;1232;333;118;2.47;35.2;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Electrical and Electronic Engineering (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2)"
236;22410;Inflammation Research;journal;1420908X, 10233830;0.664;Q2;94;150;399;4967;729;396;1.77;33.11;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
237;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.664;Q2;76;82;267;2538;603;250;1.99;30.95;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
238;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.664;Q2;75;76;189;2902;474;185;2.58;38.18;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
239;20570;Chemotherapy;journal;00093157, 14219794;0.662;Q2;58;76;214;2260;457;210;2.23;29.74;Switzerland;Western Europe;S. Karger AG;1960-2021;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
240;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.661;Q2;62;46;146;1902;279;140;1.54;41.35;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
241;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.66;Q2;83;282;839;19205;2163;815;2.67;68.1;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
242;16533;Phytochemical Analysis;journal;09580344, 10991565;0.656;Q2;76;77;209;2083;399;206;1.86;27.05;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
243;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.655;Q1;124;181;617;7498;1333;609;2.11;41.43;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
244;20027;BMC Pharmacology;journal;14712210;0.649;Q2;44;16;58;550;123;58;2.23;34.38;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
245;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.649;Q2;53;109;256;2904;491;249;1.93;26.64;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
246;110172;Progress in Drug Research;book series;0071786X;0.648;Q1;44;0;33;0;105;30;3.9;0;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
247;23039;Journal of Liposome Research;journal;08982104, 15322394;0.647;Q1;53;38;88;1418;173;86;1.88;37.32;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q1)
248;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;0.645;Q1;36;18;63;2101;145;63;1.9;116.72;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2)"
249;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.642;Q2;77;86;257;4128;571;248;2.27;48;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
250;21194;Pharmacology;journal;00317012, 14230313;0.636;Q2;60;88;270;3377;495;243;1.69;38.38;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
251;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.634;Q2;80;78;214;1991;484;184;1.79;25.53;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
252;18077;Fitoterapia;journal;0367326X, 18736971;0.631;Q2;110;227;380;6349;843;379;2.1;27.97;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
253;21229;Drug News and Perspectives;journal;02140934;0.629;Q2;51;73;215;4193;377;211;1.83;57.44;Spain;Western Europe;Prous Science;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
254;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.625;Q2;63;119;303;4100;483;279;1.54;34.45;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
255;15840;Journal of Antibiotics;journal;00218820, 18811469;0.619;Q2;84;137;312;3172;533;308;1.64;23.15;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
256;20770;Drug Delivery;journal;10717544, 15210464;0.618;Q1;72;66;190;2481;332;188;1.45;37.59;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
257;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.615;Q2;52;97;148;1859;211;126;1.39;19.16;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
258;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.615;Q1;81;51;137;2176;320;134;2.09;42.67;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
259;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.612;Q1;62;74;204;2198;271;201;1.07;29.7;United States;Northern America;Informa Healthcare;1996-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
260;4700152612;Current Nanoscience;journal;15734137;0.61;Q1;47;88;163;4067;334;162;2.12;46.22;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2)"
261;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.604;Q2;95;330;985;8481;1789;985;1.67;25.7;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
262;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.604;Q2;70;78;202;2869;433;195;2.25;36.78;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3)"
263;13671;Biologicals;journal;10958320, 10451056;0.602;Q2;60;113;181;3214;327;167;1.89;28.44;United States;Northern America;Academic Press Inc.;1990-2021;"Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3)"
264;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.598;Q1;73;60;129;2336;242;110;2.43;38.93;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
265;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.596;Q1;48;84;189;1424;183;121;0.97;16.95;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
266;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.594;Q2;74;60;231;2377;456;230;1.83;39.62;United States;Northern America;Wiley-Blackwell;1986-2021;"Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Bioengineering (Q3); Molecular Medicine (Q3)"
267;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.591;Q2;85;279;750;6880;1099;749;1.37;24.66;United States;Northern America;Wiley-Blackwell;1918-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Catalysis (Q3); Inorganic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
268;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.59;Q2;54;23;66;980;150;64;2.32;42.61;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
269;19900192900;Molecular Informatics;journal;18681751, 18681743;0.59;Q2;70;66;314;3097;716;305;1.73;46.92;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3)"
270;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.589;Q3;76;276;811;5075;1075;808;1.29;18.39;United States;Northern America;Springer New York;1966-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q3)"
271;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.586;Q1;59;18;373;1038;786;365;2.18;57.67;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Chemical Health and Safety (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
272;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.579;Q1;65;70;234;2120;440;232;1.87;30.29;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
273;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;0.573;Q1;80;78;195;3787;533;188;2.74;48.55;United States;Northern America;American Scientific Publishers;2007-2020;"Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
274;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.57;Q1;60;40;120;788;295;120;2.05;19.7;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
275;23412;Journal of AOAC International;journal;10603271;0.57;Q2;90;245;645;6179;880;633;1.25;25.22;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Pharmacology (Q2); Environmental Chemistry (Q3)"
276;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.569;Q2;63;109;256;2651;382;238;1.43;24.32;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q3)"
277;26370;Molecules;journal;14203049;0.565;Q2;171;648;873;28790;2071;863;2.19;44.43;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Analytical Chemistry (Q2); Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
278;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.564;Q2;50;85;267;1679;432;266;1.78;19.75;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Organic Chemistry (Q3)"
279;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.56;Q2;21;9;24;277;42;24;2.08;30.78;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2011;"Pharmacology (Q2); Immunology (Q3)"
280;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.558;Q2;93;252;712;7988;1301;701;1.83;31.7;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q2); Molecular Medicine (Q3); Organic Chemistry (Q3)"
281;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.556;Q2;62;90;398;2953;446;394;1.04;32.81;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Pharmacology (Q2); Veterinary (miscellaneous) (Q2)"
282;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.553;Q3;48;78;22;8855;48;21;1.13;113.53;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q3); Toxicology (Q3)"
283;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.551;Q3;62;74;189;3630;348;184;1.64;49.05;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
284;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0.548;Q2;68;90;330;7820;536;322;1.55;86.89;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery (Q2)
285;24578;Mathematical Medicine and Biology;journal;14778599;0.544;Q2;46;7;69;257;93;69;1.29;36.71;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
286;25864;Heterocycles;journal;03855414;0.534;Q2;66;386;1117;13529;1272;1106;1.14;35.05;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Pharmacology (Q2); Analytical Chemistry (Q3); Organic Chemistry (Q3)"
287;5800173401;Current Bioactive Compounds;journal;15734072;0.532;Q1;27;22;70;1777;102;62;1.34;80.77;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
288;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.531;Q2;28;27;79;2260;145;79;1.4;83.7;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2015;"Cardiology and Cardiovascular Medicine (Q2); Drug Discovery (Q2); Pharmacology (medical) (Q2)"
289;20634;Journal of Texture Studies;journal;00224901, 17454603;0.521;Q2;57;52;122;1644;116;121;0.72;31.62;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q2); Pharmaceutical Science (Q2)"
290;21264;Drugs in R and D;journal;11796901, 11745886;0.516;Q2;47;28;84;821;193;83;2.47;29.32;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q2)
291;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.516;Q2;53;91;276;4148;505;271;1.62;45.58;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
292;6400153120;Chinese Medicine;journal;17498546;0.515;Q2;45;42;54;1652;131;51;1.85;39.33;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
293;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.509;Q2;66;45;130;1752;264;125;2.15;38.93;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Drug Discovery (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3)"
294;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.509;Q2;51;139;641;3528;695;635;1.04;25.38;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
295;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.508;Q3;31;23;75;1569;126;70;1.59;68.22;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
296;5800173386;Current Drug Safety;journal;15748863;0.508;Q2;37;50;97;2717;204;91;2.18;54.34;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q3)"
297;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.504;Q2;81;78;204;2541;326;204;1.65;32.58;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Pharmaceutical Science (Q2); Bioengineering (Q3); Colloid and Surface Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
298;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X, 22124071;0.504;Q3;0;0;0;0;0;0;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2020;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3)"
299;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.503;Q2;25;23;91;2385;153;90;1.81;103.7;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q3)"
300;19300156901;Dose-Response;journal;15593258;0.501;Q3;41;44;40;2031;130;40;3.25;46.16;United States;Northern America;International Dose-Response Society;2008-2021;"Chemical Health and Safety (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
301;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.497;Q2;26;23;35;373;55;35;1.57;16.22;Bangladesh;Asiatic Region;Bangladesh Pharmacological Society;2009-2021;Pharmacology (Q2)
302;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.494;Q2;50;109;163;3836;164;163;0.73;35.19;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Pharmacology (Q2); Biophysics (Q3); Cell Biology (Q4)"
303;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.485;Q3;40;38;116;2004;181;115;1.71;52.74;United States;Northern America;Informa Healthcare;2004-2021;"Immunology (Q3); Toxicology (Q3)"
304;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.484;Q3;38;37;139;1096;170;138;1.18;29.62;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
305;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.476;Q1;91;170;557;5470;898;552;1.34;32.18;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
306;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;0.476;Q2;76;140;120;10130;128;89;1.07;72.36;United Kingdom;Western Europe;Future Science;2009-2021;"Pharmacology (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
307;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.474;Q3;42;30;93;1000;173;92;1.6;33.33;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Safety Research (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
308;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.47;Q2;61;42;166;1732;273;166;1.61;41.24;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
309;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.468;Q1;36;6;49;264;102;47;2.03;44;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
310;25106;Human and Experimental Toxicology;journal;09603271;0.465;Q3;82;124;353;3906;543;327;1.26;31.5;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
311;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.465;Q2;67;133;374;2399;363;341;1.13;18.04;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q2)"
312;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.464;Q2;52;92;412;2498;474;359;1.14;27.15;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3)"
313;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.462;Q3;47;33;95;1264;149;95;1.38;38.3;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
314;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;0.461;Q3;29;29;82;2446;143;82;2.07;84.34;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Immunology and Allergy (Q3)"
315;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.456;Q3;23;0;87;0;132;71;1.9;0;Finland;Western Europe;Finnish Institute of Occupational Health;2005-2011, 2016-2018;"Geography, Planning and Development (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
316;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.447;Q3;61;95;278;2327;341;224;1.19;24.49;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Medical Laboratory Technology (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
317;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.445;Q2;79;117;410;3785;690;408;1.61;32.35;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
318;27210;In Vivo;journal;17917549, 0258851X;0.442;Q2;64;155;453;4212;606;453;1.29;27.17;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
319;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.436;Q3;69;154;302;2797;456;283;1.45;18.16;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
320;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.435;Q3;50;44;132;2032;308;129;2.16;46.18;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
321;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.418;Q3;46;48;219;1854;345;219;1.49;38.63;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q3)
322;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.412;Q2;61;163;551;3071;773;550;1.02;18.84;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
323;18800156720;Dissolution Technologies;journal;1521298X;0.41;Q2;34;30;64;358;55;58;0.93;11.93;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
324;4100151616;Supportive Cancer Therapy;journal;15432912;0.41;Q3;14;0;28;0;40;26;0;0;United States;Northern America;Cancer Information Group, LP;2006-2007;"Cancer Research (Q3); Oncology (Q3); Pharmacology (Q3)"
325;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.409;Q2;40;72;149;1227;124;141;0.68;17.04;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
326;26767;Altex;journal;1868596X, 18688551;0.407;Q3;57;30;136;794;163;126;1.87;26.47;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
327;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.406;Q3;21;24;54;384;64;54;1.5;16;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
328;19700175230;Drug Design, Development and Therapy;journal;11778881;0.404;Q2;71;33;52;2438;83;49;1.63;73.88;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
329;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.403;Q3;48;167;414;2850;355;409;1.04;17.07;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
330;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.397;Q1;69;223;449;2862;570;405;1.16;12.83;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
331;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.397;Q3;51;165;535;5065;499;506;0.85;30.7;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
332;24071;Metal-Based Drugs;journal;07930291, 16875486;0.395;Q3;38;4;26;266;55;24;2.48;66.5;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q3); Inorganic Chemistry (Q3); Pharmacology (Q3); Toxicology (Q3)"
333;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.394;Q3;53;86;213;3337;257;212;1.01;38.8;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
334;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.391;Q1;61;124;408;3642;609;404;1.34;29.37;China;Asiatic Region;Zhejiang University Press;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
335;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.387;Q2;54;38;105;1129;118;96;0.9;29.71;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
336;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.375;Q1;23;10;34;342;37;33;1.04;34.2;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
337;21192;Drug Development Research;journal;02724391, 10982299;0.374;Q3;62;55;172;2134;190;156;1.15;38.8;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
338;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.371;Q3;48;38;133;766;124;128;0.95;20.16;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q2); Dentistry (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
339;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.37;Q3;53;93;211;3885;242;210;1.07;41.77;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
340;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.367;Q3;50;413;846;9844;785;829;0.94;23.84;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Plant Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
341;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.367;Q2;42;80;212;2105;286;211;1.24;26.31;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q2)
342;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.366;Q1;50;104;172;2637;215;172;1.04;25.36;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3)"
343;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.363;Q3;62;78;192;2819;249;184;1.12;36.14;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
344;21717;Die Pharmazie;journal;00317144;0.361;Q2;66;167;543;4710;605;541;1.07;28.2;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
345;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;0.361;Q1;50;153;370;4814;355;357;0.7;31.46;Brazil;Latin America;Springer Nature Switzerland AG;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
346;19700174891;Perspectives in Medicinal Chemistry;journal;11773910, 1177391X;0.36;Q2;16;3;10;113;15;10;1.5;37.67;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2011, 2014-2016;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
347;4700152608;African Journal of Traditional, Complementary and Alternative Medicines (discontinued);journal;25050044, 01896016;0.353;Q3;48;48;148;1114;157;144;0.77;23.21;Nigeria;Africa;African Ethnomedicines Network;2006-2017;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
348;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.352;Q2;57;81;81;2301;114;73;1.41;28.41;United Kingdom;Western Europe;John Wiley and Sons Ltd;2009-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Environmental Chemistry (Q4); Spectroscopy (Q4)"
349;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;0.351;Q2;28;35;141;727;137;138;1.07;20.77;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019, 2021;"Biochemistry (medical) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Clinical Biochemistry (Q3)"
350;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.35;Q2;42;159;488;2639;416;488;0.78;16.6;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
351;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.348;Q3;58;169;414;3642;820;404;2.27;21.55;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
352;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.345;Q3;64;42;104;1158;100;88;1.03;27.57;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
353;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.345;Q1;48;63;128;1446;112;116;0.85;22.95;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
354;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.343;Q3;32;51;99;1201;124;98;1.02;23.55;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
355;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.34;Q3;46;53;125;1796;142;125;1.06;33.89;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
356;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.34;Q2;39;120;224;1659;106;204;0.38;13.83;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q3)"
357;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;0.339;Q3;56;33;51;2177;45;44;0.88;65.97;United Kingdom;Western Europe;SAGE Publications Ltd;2008-2021;"Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (Q3)"
358;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.334;Q2;48;153;498;3854;376;496;0.77;25.19;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
359;144963;Drug Discovery Today: Disease Models;journal;17406757;0.33;Q3;28;19;96;746;61;82;0.65;39.26;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q3); Molecular Medicine (Q3)"
360;110097;Food and Drug Law Journal;journal;1064590X;0.329;Q3;22;35;117;7167;62;117;0.57;204.77;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
361;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.327;Q3;39;11;96;224;70;94;0.51;20.36;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
362;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.326;Q3;49;95;120;5641;122;92;1.02;59.38;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2021;"Biochemistry (medical) (Q3); Clinical Biochemistry (Q3); Drug Discovery (Q3)"
363;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.321;Q3;24;18;74;1885;73;71;0.98;104.72;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q3); Pharmacology (Q3)"
364;12000154522;Advances in Antiviral Drug Design;book series;10758593;0.32;Q2;12;0;7;0;6;6;0;0;United Kingdom;Western Europe;Elsevier Ltd.;1996, 1999, 2003, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Infectious Diseases (Q3); Pharmacology (medical) (Q3); Virology (Q3)"
365;19700174961;BioProcess International;trade journal;15426319;0.319;Q3;23;141;150;737;51;147;0.34;5.23;United States;Northern America;PJB Publications Ltd.;2009-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Drug Discovery (Q3)"
366;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.319;Q3;29;12;101;524;71;86;0.71;43.67;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
367;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.318;Q3;41;0;36;0;38;15;1.06;0;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q3); Organic Chemistry (Q3)"
368;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.317;Q3;27;31;89;1578;77;78;0.85;50.9;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Molecular Medicine (Q3)"
369;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.315;Q2;72;227;440;6719;374;434;0.78;29.6;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
370;17500155003;Records of Natural Products;journal;13076167;0.315;Q3;33;34;23;1052;22;23;0.96;30.94;Turkey;Middle East;ACG Publications;2009-2022;"Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Plant Science (Q3)"
371;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.309;Q2;52;56;185;3286;136;183;0.7;58.68;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
372;19700175099;Topics in Medicinal Chemistry;book series;1862247X, 18622461;0.306;Q3;12;15;10;1612;7;8;0.7;107.47;Germany;Western Europe;Springer Verlag;2009-2012, 2014-2021;"Drug Discovery (Q3); Molecular Medicine (Q3)"
373;19700188217;Bioanalysis;journal;17576180, 17576199;0.298;Q2;62;176;128;6229;140;113;1.09;35.39;United Kingdom;Western Europe;Future Science;2009-2021;"Medical Laboratory Technology (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Analytical Chemistry (Q3); Clinical Biochemistry (Q3); Medicine (miscellaneous) (Q3)"
374;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.295;Q3;62;121;233;2017;219;190;0.77;16.67;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
375;11200153306;Journal of Pharmacology and Toxicology (discontinued);journal;1816496X, 2152100X;0.294;Q2;18;11;88;320;55;88;0.63;29.09;United States;Northern America;Academic Journals Inc.;2008-2017;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
376;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.293;Q3;47;48;150;1092;131;149;0.93;22.75;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
377;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.293;Q2;33;25;71;1133;97;71;1.78;45.32;Spain;Western Europe;Elsevier Espana;2005-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3)"
378;19700174987;Research Journal of Toxins (discontinued);journal;18193560, 21517258;0.293;Q3;3;0;2;0;2;2;1;0;United States;Northern America;Academic Journals Inc.;2009, 2014, 2016;"Agronomy and Crop Science (Q2); Food Science (Q2); Toxicology (Q3)"
379;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.292;Q3;32;39;47;1187;49;46;1.04;30.44;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Food Science (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
380;19700175105;Open Drug Delivery Journal;journal;18741266;0.291;Q2;5;8;3;172;4;3;1.33;21.5;Netherlands;Western Europe;;;Pharmaceutical Science (Q2)
381;20065;BioPharm International;trade journal;1542166X, 19391862;0.288;Q2;29;99;361;657;120;312;0.36;6.64;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
382;10900153302;Biomarker Insights;journal;11772719;0.286;Q3;35;19;43;621;47;43;1.09;32.68;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2021;"Biochemistry (medical) (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
383;25144;Journal of Health Science;journal;13475207, 13449702;0.284;Q3;49;92;354;3185;307;352;0.86;34.62;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
384;73430;Pharmaceutical Technology;journal;15432521;0.284;Q2;38;175;582;628;114;446;0.19;3.59;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q3)"
385;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;0.283;Q3;39;112;231;4356;191;231;0.92;38.89;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology (Q3)
386;19700174931;Asian Journal of Pharmaceutics (discontinued);journal;1998409X, 09738398;0.281;Q2;23;47;61;1198;44;55;0.72;25.49;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
387;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.281;Q3;19;32;53;2735;60;48;1.13;85.47;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2018, 2020;"Molecular Medicine (Q3); Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4)"
388;21211;Pharmacy Education;journal;14772701, 15602214;0.281;Q2;18;20;67;338;42;67;0.68;16.9;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Education (Q3)"
389;35190;Revista Espanola de Quimioterapia;journal;02143429;0.279;Q3;26;38;139;921;111;124;0.75;24.24;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
390;20578;Journal of Food and Drug Analysis;journal;10219498;0.278;Q3;63;53;199;1488;169;197;0.75;28.08;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q3); Pharmacology (Q3)"
391;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.278;Q3;46;74;230;3336;243;224;1.1;45.08;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
392;15340;Developments in Biologicals;journal;14246074, 16622960;0.277;Q3;38;1;213;0;167;206;1.1;0;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Pharmacology (Q3); Biomaterials (Q4); Immunology (Q4)"
393;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.275;Q2;57;39;144;1052;117;142;0.68;26.97;United States;Northern America;Informa Healthcare;2013-2021;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3)"
394;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.272;Q3;25;25;10;1393;7;9;0.7;55.72;New Zealand;Pacific Region;Dove Medical Press Limited;2009-2021;"Health Policy (Q3); Pharmacology (Q3)"
395;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.272;Q2;28;37;99;975;68;99;0.6;26.35;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
396;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.264;Q3;40;48;49;2652;58;48;1.18;55.25;Netherlands;Western Europe;Wageningen Academic Publishers;2009-2021;"Food Science (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
397;21496;Revista de Chimie (discontinued);journal;00347752;0.263;-;31;258;861;4964;544;859;0.7;19.24;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
398;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.262;Q2;17;17;36;409;15;35;0.43;24.06;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
399;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.261;Q3;29;0;32;0;33;31;0;0;United States;Northern America;The Haworth Herbal Press;2001-2008;"Pharmacology (Q3); Biochemistry (Q4)"
400;19400158813;HIV Therapy;journal;17584329, 17584310;0.26;Q3;12;48;60;4159;25;42;0.42;86.65;United Kingdom;Western Europe;Future Medicine Ltd.;2009-2010;"Dermatology (Q3); Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Virology (Q4)"
401;25171;Mycotoxin Research;journal;18671632, 01787888;0.26;Q3;40;34;89;1165;67;80;0.82;34.26;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q3); Toxicology (Q3); Microbiology (Q4)"
402;19200156706;Pharmacognosy Magazine (discontinued);journal;09731296, 09764062;0.26;Q2;42;67;161;1593;107;157;0.66;23.78;India;Asiatic Region;Wolters Kluwer Medknow Publications;2008-2018, 2020-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
403;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.259;Q3;24;74;228;1345;130;46;0.45;18.18;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
404;130089;Toxin Reviews;journal;15569543, 15569551;0.258;Q3;46;11;67;966;69;64;1.08;87.82;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q3)
405;20572;PZ Prisma;journal;09455566;0.257;Q2;5;34;97;588;9;85;0.13;17.29;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
406;130038;Letters in Drug Design and Discovery;journal;15701808;0.256;Q2;35;114;283;3563;216;283;0.7;31.25;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
407;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.255;Q2;26;27;34;1156;26;26;0.76;42.81;United States;Northern America;Lumitext Publishing;2009-2017, 2020-2021;"Pharmaceutical Science (Q2); Molecular Biology (Q4)"
408;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.253;Q3;34;27;52;897;39;52;0.75;33.22;Slovakia;Eastern Europe;Slovak Toxicology Society SETOX;2008-2020;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
409;19700174969;Archives of Drug Information;journal;17535174;0.251;Q2;11;7;24;136;18;23;0.75;19.43;United States;Northern America;"John Wiley &amp; Sons Inc.";2008-2011;"Complementary and Alternative Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
410;21100470510;Drug Research;journal;21949379, 21949387;0.247;Q3;65;126;384;3189;292;378;0.65;25.31;Germany;Western Europe;Thieme;1972, 2013-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
411;10900153328;Frontiers in Drug Design and Discovery;book series;15740889, 22121064;0.246;Q2;9;0;41;0;33;39;0.56;0;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2007, 2009, 2016-2018;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
412;4700152607;Current Enzyme Inhibition;journal;15734080;0.245;Q3;18;23;65;2088;47;65;0.6;90.78;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
413;19700175244;Current Radiopharmaceuticals;journal;18744710, 18744729;0.245;Q3;26;22;33;1723;25;30;0.76;78.32;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2021;"Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
414;23171;Korean Journal of Pharmacognosy;journal;02533073;0.245;Q2;17;56;197;1178;77;197;0.44;21.04;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
415;17700156714;Pharmaceuticals;journal;14248247;0.243;Q2;69;185;23;18278;15;22;0.65;98.8;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Pharmaceutical Science (Q2); Molecular Medicine (Q4)"
416;23489;Chemical Speciation and Bioavailability;journal;09542299;0.242;Q4;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
417;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.24;Q2;25;17;56;520;24;53;0.45;30.59;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmaceutical Science (Q2); Pharmacology (nursing) (Q2); Sports Science (Q3)"
418;19446;American Pharmaceutical Review;journal;10998012;0.238;Q2;24;86;301;1240;119;301;0.45;14.42;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q2)
419;59665;Chinese Journal of Natural Medicines;journal;16723651;0.236;Q3;40;48;283;866;139;279;0.56;18.04;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
420;11200153304;Future HIV Therapy;journal;17469600, 17469619;0.236;Q3;8;0;57;0;34;46;0.6;0;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2009;"Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Virology (Q4)"
421;22881;Yaoxue Xuebao;journal;05134870;0.236;Q2;34;259;704;5323;422;703;0.64;20.55;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
422;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.235;Q3;35;176;501;2025;259;501;0.59;11.51;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
423;24097;Journal of the Indian Chemical Society;journal;00194522;0.235;Q3;33;210;713;5508;263;703;0.38;26.23;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q3); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
424;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.235;Q3;19;25;47;202;37;47;0.85;8.08;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Drug Guides (Q2); Pharmacy (Q2); Pharmacology (Q3)"
425;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;1943085X, 19430906;0.234;Q2;15;5;11;391;13;10;1.18;78.2;United States;Northern America;Taylor and Francis Ltd.;2009-2012;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Nanoscience and Nanotechnology (Q4)"
426;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.234;Q3;33;44;108;1245;68;107;0.66;28.3;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
427;19700175039;Open Toxicology Journal;journal;18743404;0.229;Q4;8;8;7;209;6;7;0.86;26.13;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2010, 2012-2013;Toxicology (Q4)
428;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.228;Q3;29;21;93;455;47;93;0.52;21.67;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
429;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.228;Q2;43;233;654;4830;401;624;0.56;20.73;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
430;19200156925;Cancer Therapy;journal;15439143, 15439135;0.227;Q3;8;18;47;668;13;47;0.28;37.11;United States;Northern America;Gene Therapy Press;2009-2014;"Oncology (Q3); Pharmacology (Q3); Cancer Research (Q4)"
431;19700175149;African Journal Biomedical Research;journal;11195096;0.226;Q2;17;36;47;806;31;47;0.66;22.39;Nigeria;Africa;Ibadan Biomedical Communications Group;2008, 2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3)"
432;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.224;Q2;19;38;140;835;52;116;0.38;21.97;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Marketing (Q3); Medicine (miscellaneous) (Q3); Strategy and Management (Q3)"
433;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.223;Q2;46;56;114;1391;97;113;0.89;24.84;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
434;21810;Farmacia;journal;00148237;0.22;Q2;27;91;168;1386;169;168;1.01;15.23;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
435;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.22;Q3;53;53;180;1308;104;148;0.58;24.68;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
436;21265;Drugs of the Future;journal;03778282;0.218;Q3;45;113;350;7369;195;349;0.53;65.21;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
437;10300153301;Expert Review of Clinical Pharmacology;journal;17512433, 17512441;0.218;Q2;46;68;129;5932;94;110;0.73;87.24;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
438;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;0.218;Q2;53;84;130;5176;68;118;0.52;61.62;United States;Northern America;Springer New York;2008-2021;"Pharmaceutical Science (Q2); Cardiology and Cardiovascular Medicine (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Medicine (Q4)"
439;5400152620;American Journal of Pharmacology and Toxicology (discontinued);journal;15574970, 15574962;0.217;Q2;21;22;71;700;56;71;0.92;31.82;United States;Northern America;Science Publications;2007-2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
440;22908;Chinese Pharmacological Bulletin;journal;10011978;0.217;Q3;17;425;1241;6484;758;1241;0.7;15.26;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q3)
441;5800179590;Pharmacologyonline (discontinued);journal;18278620;0.217;Q3;27;305;777;7950;301;776;0.37;26.07;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2021;"Pharmacology (Q3); Drug Discovery (Q4)"
442;19700175819;Patient Preference and Adherence;journal;1177889X;0.216;Q2;54;30;108;1137;80;107;0.83;37.9;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3); Medicine (miscellaneous) (Q3); Social Sciences (miscellaneous) (Q3)"
443;19600156803;Journal of Medicinal Plant Research;journal;19960875;0.215;Q3;63;371;193;12026;153;187;0.79;32.42;Nigeria;Africa;Academic Journals;2009-2012;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3); Plant Science (Q3); Drug Discovery (Q4)"
444;4500151530;Personalized Medicine;journal;17410541;0.215;Q3;33;92;200;2879;136;161;0.69;31.29;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
445;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.213;Q4;32;77;178;2021;76;163;0.36;26.25;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Animal Science and Zoology (Q3); Infectious Diseases (Q3); Parasitology (Q4); Toxicology (Q4)"
446;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.212;Q3;45;109;299;2362;220;299;0.71;21.67;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
447;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.212;Q3;44;60;126;2263;66;126;0.52;37.72;South Korea;Asiatic Region;Korean Society of Applied Pharmacology;2008-2021;"Pharmacology (Q3); Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
448;79053;Natural Product Sciences;journal;12263907;0.212;Q4;28;50;173;1226;66;173;0.37;24.52;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
449;22375;Indian Drugs;journal;0019462X;0.211;Q3;31;144;470;2372;127;469;0.19;16.47;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
450;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.211;Q3;22;25;110;635;50;110;0.49;25.4;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q3)
451;21102;Pharmaceutical Journal;journal;00316873;0.211;Q3;28;849;3171;639;113;864;0.03;0.75;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
452;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.21;Q3;30;65;221;2782;63;213;0.32;42.8;United States;Northern America;Current Medicine Group;2007-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
453;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.209;Q4;37;51;151;2352;148;148;1.02;46.12;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
454;58808;Pharmaceutical Care and Research;journal;16712838;0.209;Q3;8;159;453;1365;46;448;0.08;8.58;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
455;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.202;Q3;29;52;195;1810;65;195;0.25;34.81;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
456;21758;Prescrire International;journal;11677422;0.196;Q3;13;191;634;1297;125;534;0.21;6.79;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
457;15842;Journal of Applied Research;journal;1537064X;0.195;Q3;22;16;73;415;24;67;0.42;25.94;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
458;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996, 15969827;0.195;Q3;39;73;72;1382;70;66;0.97;18.93;Nigeria;Africa;Pharmacotherapy Group;2009-2021;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
459;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.194;Q3;36;28;76;915;41;76;0.53;32.68;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4); Physiology (Q4)"
460;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.194;Q3;19;223;658;1841;36;628;0.05;8.26;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
461;21207;Drug Discovery Today: Technologies;journal;17406749;0.193;Q4;53;35;50;1374;35;43;0.69;39.26;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
462;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.19;Q3;11;143;392;1075;28;359;0.07;7.52;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Pharmacology (nursing) (Q2); Pharmacy (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
463;21100301409;Issues in Toxicology;book series;17577179, 17577187;0.19;Q3;16;36;69;2414;32;64;0.65;67.06;United Kingdom;Western Europe;Royal Society of Chemistry;2007-2021;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
464;21142;Pharmaceutisch Weekblad;journal;00316911;0.188;Q3;9;425;1220;640;20;751;0.02;1.51;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
465;19408;Actualites Pharmaceutiques;journal;05153700;0.187;Q3;5;146;547;313;11;498;0.03;2.14;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
466;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.187;Q3;9;60;132;965;21;124;0.11;16.08;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
467;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.186;Q4;28;21;64;498;14;51;0.19;23.71;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
468;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.185;Q3;33;64;165;2030;77;165;0.56;31.72;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q3); Physiology (Q4)"
469;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.185;Q3;20;117;232;441;82;225;0.35;3.77;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
470;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.185;Q3;16;27;56;699;27;56;0.54;25.89;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
471;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;0.184;Q3;50;14;22;649;15;21;0.68;46.36;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Internal Medicine (Q3); Pharmacology (Q3)"
472;130031;Journal of Toxicologic Pathology;journal;09149198;0.184;Q4;30;36;95;1159;46;95;0.42;32.19;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
473;19700175040;Open Vaccine Journal;journal;18750354;0.183;Q3;9;24;13;932;12;13;0.92;38.83;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4)"
474;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.182;Q3;24;13;98;191;49;98;0.28;14.69;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q3)
475;20564;Ceska a Slovenska Farmacie;journal;12107816;0.181;Q3;17;36;124;802;46;120;0.33;22.28;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
476;17700156431;Handbook of Analytical Separations;book series;15677192;0.181;Q2;12;0;32;0;7;0;0.22;0;Netherlands;Western Europe;Elsevier;2000-2001, 2003-2004, 2008, 2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Analytical Chemistry (Q4); Environmental Chemistry (Q4)"
477;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.18;Q2;43;90;255;2905;102;245;0.3;32.28;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
478;20684;Current Pharmacogenomics;journal;15701603;0.18;Q3;12;0;27;0;17;27;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2004-2007;"Pharmacology (Q3); Genetics (Q4)"
479;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.178;Q3;14;18;113;1632;44;102;0.37;90.67;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q3); Pharmacology (Q3); Immunology and Allergy (Q4)"
480;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.177;Q3;22;66;110;1715;36;97;0.33;25.98;Chile;Latin America;MS-Editions;2008-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3); Drug Discovery (Q4); Plant Science (Q4)"
481;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.177;Q3;34;22;55;567;17;49;0.4;25.77;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
482;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.177;Q4;12;24;87;620;19;87;0.19;25.83;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
483;13718;Pharmaceutical Engineering;journal;02738139;0.177;Q3;16;41;153;249;20;137;0.12;6.07;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
484;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.176;Q4;14;25;55;748;24;55;0.44;29.92;United Kingdom;Western Europe;Inderscience Enterprises Ltd;2008-2021;"Computer Science Applications (Q4); Drug Discovery (Q4)"
485;22205;Saudi Pharmaceutical Journal;journal;13190164;0.176;Q3;57;31;98;1495;38;96;0.31;48.23;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
486;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.175;Q2;17;27;78;791;28;68;0.39;29.3;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
487;19500156813;Procedia in Vaccinology;journal;1877282X;0.175;Q3;15;35;32;724;14;32;0.44;20.69;Netherlands;Western Europe;Elsevier;2009-2012;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4); Infectious Diseases (Q4)"
488;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;0.173;Q3;5;1;12;203;4;11;0.33;203;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2012;"Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
489;17600155051;Drug Development and Delivery;trade journal;1944818X, 15372898;0.172;Q3;11;103;81;728;14;72;0.17;7.07;United States;Northern America;Drug Delivery Technology;2009-2021;Pharmaceutical Science (Q3)
490;19700177006;Psychopharm Review;trade journal;19369255;0.172;Q3;4;12;12;554;2;12;0.17;46.17;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2009-2014;"Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
491;5800173394;Current Drug Therapy;journal;15748855;0.171;Q2;17;37;77;2475;50;74;0.66;66.89;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
492;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.171;Q3;42;33;122;951;57;119;0.56;28.82;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
493;19700188352;Toxins;journal;20726651;0.171;Q4;91;152;16;14073;10;15;0.63;92.59;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
494;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.169;Q3;20;56;72;1148;24;72;0.26;20.5;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q3)
495;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences (discontinued);journal;09751491;0.169;Q3;49;310;77;6694;43;77;0.56;21.59;India;Asiatic Region;IJPPS;2009-2017, 2020-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
496;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.169;Q3;21;20;85;564;36;85;0.15;28.2;Iran;Middle East;Academy of Medical Sciences of I.R. Iran;2006-2015;Pharmacology (Q3)
497;19700174900;International Journal of Green Pharmacy (discontinued);journal;19984103, 09738258;0.168;Q3;26;55;68;1552;40;64;0.59;28.22;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
498;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.168;Q3;13;77;247;787;44;210;0.18;10.22;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
499;19700170617;EXCLI Journal;journal;16112156;0.167;Q3;43;20;28;630;17;27;0.61;31.5;Germany;Western Europe;Leibniz Research Centre for Working Environment and Human Factors;2009-2021;"Pharmacology (Q3); Animal Science and Zoology (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
500;19700171017;African Journal of Pharmacy and Pharmacology;journal;19960816;0.166;Q3;33;126;102;3676;53;102;0.52;29.17;Nigeria;Africa;Academic Journals;2009-2011;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
501;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.166;Q3;24;127;298;2389;99;298;0.33;18.81;India;Asiatic Region;Rasayan Journal;2008-2021;"Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4)"
502;73076;Drug Discovery World;journal;14694344;0.164;Q4;13;59;125;457;45;113;0.43;7.75;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
503;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.164;Q3;5;39;156;1133;10;153;0.06;29.05;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
504;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.164;Q3;22;52;127;939;47;120;0.37;18.06;India;Asiatic Region;Association of Pharmaceutical Teachers of India;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
505;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.164;Q3;9;20;80;303;11;65;0.15;15.15;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
506;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.163;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
507;145693;Canadian Pharmacists Journal;journal;17151635;0.163;Q3;24;112;301;884;38;186;0.15;7.89;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
508;19700175071;Open Bioactive Compounds Journal;journal;18748473;0.163;Q3;6;3;3;134;3;3;1;44.67;Netherlands;Western Europe;;;"Pharmaceutical Science (Q3); Pharmacology (Q3); Biochemistry (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
509;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.161;Q3;27;40;158;1723;71;144;0.51;43.08;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
510;19700175060;International Journal of PharmTech Research (discontinued);journal;09744304;0.161;Q3;48;389;275;8489;135;275;0.49;21.82;India;Asiatic Region;Sphinx Knowledge House;2009-2016;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
511;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.16;Q3;7;0;40;0;5;31;0.13;0;United States;Northern America;Haworth Press Inc.;2003-2008;"Pharmaceutical Science (Q3); Health Policy (Q4); Pharmacology (Q4)"
512;21100226424;Toxicology and Environmental Health Sciences;journal;20059752, 22337784;0.16;Q4;17;39;30;1167;7;30;0.23;29.92;South Korea;Asiatic Region;Korean Society of Environmental Risk Assessment and Health Science;2009-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
513;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.159;Q4;19;0;30;0;17;26;0.33;0;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q4)"
514;17700156705;Modern Trends in Pharmacopsychiatry;journal;16622685, 16624505;0.157;Q4;0;0;0;0;0;0;0;0;Switzerland;Western Europe;S. Karger AG;2009-2010, 2013, 2015, 2017;"Medicine (miscellaneous) (Q3); Psychiatry and Mental Health (Q3); Pharmacology (Q4)"
515;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.156;Q4;11;32;85;746;28;85;0.31;23.31;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
516;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.156;Q3;32;732;1880;8949;462;1880;0.22;12.23;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
517;9800153137;Trastornos Adictivos;journal;15750973;0.155;Q4;9;24;95;501;25;69;0.21;20.88;Spain;Western Europe;Ediciones Doyma, S.L.;2007-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
518;19700170837;Vitae;journal;21452660, 01214004;0.155;Q3;15;27;40;730;8;38;0.2;27.04;Colombia;Latin America;Universidad de Antioquia;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4)"
519;19600162009;Advances in Molecular Toxicology;book series;18720854, 22122044;0.153;Q4;15;8;16;1244;6;14;0.38;155.5;Netherlands;Western Europe;Elsevier;2006, 2008-2018, 2020;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
520;22934;Chinese Pharmaceutical Journal;journal;10012494;0.153;Q3;21;497;1489;6253;234;1489;0.14;12.58;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
521;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.151;Q3;6;15;45;458;14;40;0.2;30.53;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
522;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.15;Q3;14;16;69;649;12;69;0.15;40.56;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
523;11900154394;Oriental Journal of Chemistry (discontinued);journal;0970020X, 22315039;0.15;Q4;27;267;429;5365;81;429;0.19;20.09;India;Asiatic Region;Bhopal, S.A. Iqbal;1989, 2008-2018, 2021;"Chemistry (miscellaneous) (Q3); Biochemistry (Q4); Drug Discovery (Q4); Environmental Chemistry (Q4)"
524;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;0.149;Q3;13;14;90;362;27;89;0.24;25.86;France;Western Europe;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
525;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.149;Q3;13;35;89;752;18;86;0.12;21.49;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q3)
526;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.148;Q4;24;37;109;3601;31;98;0.23;97.32;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Immunology (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
527;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.147;Q3;11;17;63;555;16;63;0.13;32.65;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
528;19700174893;Dhaka University Journal of Pharmaceutical Sciences (discontinued);journal;18161839, 18161820;0.147;Q3;13;21;87;368;21;87;0.23;17.52;Bangladesh;Asiatic Region;University of Dhaka;2007-2018, 2020;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
529;12100156823;5th PCIC Europe 2008: Petroleum and Chemical Industry Conference Europe;conference and proceedings;-;0.146;-;5;0;29;0;9;28;0.31;0;United States;Northern America;;;"Chemical Engineering (miscellaneous); Electrical and Electronic Engineering; Geochemistry and Petrology; Pharmaceutical Science"
530;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.146;Q4;17;48;45;1123;7;41;0.16;23.4;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2012-2021;"Cardiology and Cardiovascular Medicine (Q3); Critical Care and Intensive Care Medicine (Q3); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
531;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.145;Q4;13;68;200;803;34;126;0.17;11.81;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
532;25253;Blutalkohol (discontinued);journal;00065250;0.144;Q4;13;40;90;866;12;87;0.1;21.65;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
533;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.144;Q4;14;52;165;1003;20;164;0.08;19.29;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q3); Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
534;19700175143;Pharmacognosy Reviews (discontinued);journal;09737847, 09762787;0.144;Q4;54;29;41;1603;10;41;0.24;55.28;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
535;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.144;Q3;18;32;127;880;30;126;0.1;27.5;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q3)
536;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.143;Q4;16;98;311;1569;61;311;0.18;16.01;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
537;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.142;Q3;7;29;103;415;6;99;0.03;14.31;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q3)
538;22338;Hospital Pharmacy;journal;19451253, 00185787;0.141;Q4;24;157;444;1744;76;378;0.12;11.11;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
539;22514;Japanese Journal of Chemotherapy;journal;13407007;0.141;Q4;12;33;138;579;15;138;0.1;17.55;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
540;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.141;Q4;14;33;79;561;6;69;0.04;17;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
541;21127;Pharmaceutical Technology Europe;journal;01646826;0.14;Q3;18;144;330;429;40;269;0.12;2.98;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q3)
542;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.139;Q3;20;192;81;2256;26;81;0.26;11.75;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
543;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;0.139;Q4;25;10;49;442;14;48;0.33;44.2;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
544;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.138;Q4;12;67;51;981;7;50;0.14;14.64;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
545;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.138;Q3;9;64;197;271;17;189;0.11;4.23;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;Pharmaceutical Science (Q3)
546;19700174933;Journal of Pharmaceutical Sciences and Research (discontinued);journal;09751459;0.138;Q3;30;125;66;2710;19;66;0.29;21.68;India;Asiatic Region;;2009-2018, 2020-2021;Pharmaceutical Science (Q3)
547;17700156303;Neuromethods;book series;19406045, 08932336;0.138;Q3;21;76;64;4822;9;58;0.14;63.45;United States;Northern America;Humana Press;2009-2022;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Neuroscience (miscellaneous) (Q4); Psychiatry and Mental Health (Q4)"
548;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.137;Q4;10;18;22;1393;10;19;0.45;77.39;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q3); Infectious Diseases (Q4); Pharmacology (Q4); Virology (Q4)"
549;4000151610;International Journal of Neuroprotection and Neuroregeneration;journal;17451183, 17451191;0.136;Q4;5;0;29;0;5;24;0.27;0;United Kingdom;Western Europe;RPA Publishers.;2006-2008;"Neurology (clinical) (Q4); Pharmacology (Q4)"
550;22906;Journal of China Pharmaceutical University;journal;10005048;0.136;Q3;14;107;373;1776;62;372;0.13;16.6;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
551;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.136;Q3;15;45;118;839;26;108;0.23;18.64;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
552;80593;Journal of Medicinal Plants;journal;16840240;0.136;Q4;23;90;203;2641;45;203;0.22;29.34;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
553;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.136;Q4;19;37;135;770;42;106;0.29;20.81;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
554;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;0.135;Q4;18;153;451;3005;34;451;0.06;19.64;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
555;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.135;Q3;35;191;393;2352;48;271;0.11;12.31;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
556;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.135;Q4;34;123;491;1973;92;489;0.15;16.04;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
557;19700175096;Pharmacognosy Journal;journal;09753575;0.135;Q4;25;139;40;2878;17;40;0.43;20.71;India;Asiatic Region;EManuscript Technologies;2009-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
558;19700174904;Asian Journal of Pharmaceutical and Clinical Research (discontinued);journal;09742441, 24553891;0.133;Q4;41;84;59;1807;22;59;0.37;21.51;India;Asiatic Region;Asian Journal of Pharmaceutical and Clinical Research;2009-2018, 2020-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
559;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.133;Q3;4;52;138;1244;12;129;0.08;23.92;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
560;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.133;Q3;10;55;98;484;15;93;0.11;8.8;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
561;17300154738;Current Trends in Biotechnology and Pharmacy;journal;22307303, 09738916;0.132;Q4;14;49;50;1768;12;50;0.24;36.08;India;Asiatic Region;Association of Biotechnology and Pharmacy;2009-2021;"Biotechnology (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4)"
562;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.132;Q4;9;45;78;789;4;78;0.04;17.53;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
563;15500154707;International Journal of Biological Chemistry (discontinued);journal;21522561, 1819155X;0.131;Q4;16;7;18;231;6;18;0.33;33;Pakistan;Asiatic Region;Asian Network for Scientific Information;2009-2016;"Biochemistry (Q4); Pharmacology (Q4)"
564;19700175061;Open Pharmacology Journal;journal;18741436;0.131;Q4;6;4;5;400;2;5;0.4;100;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
565;16893;Biogenic Amines;journal;15693910, 01688561;0.13;Q4;15;0;31;0;3;31;0;0;Slovenia;Eastern Europe;Society of Integrated Sciences;1989-2007;"Neuroscience (miscellaneous) (Q4); Pharmacology (Q4)"
566;22977;Journal de Pharmacie de Belgique;journal;00472166;0.13;Q4;12;27;88;312;10;83;0.13;11.56;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
567;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;0.13;Q3;14;0;174;0;50;173;0.5;0;Germany;Western Europe;Springer Verlag;2006-2008;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biotechnology (Q4); Chemistry (miscellaneous) (Q4)"
568;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.129;Q4;10;123;93;1785;9;93;0.1;14.51;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
569;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.128;Q4;10;24;97;794;16;95;0.18;33.08;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
570;130170;Phytotherapie;journal;17652847, 16248597;0.128;Q4;18;70;202;1672;27;145;0.13;23.89;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
571;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685, 19054637;0.128;Q4;12;14;12;468;3;12;0.25;33.43;Thailand;Asiatic Region;Thai Journal of Pharmaceutical Sciences;2009-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
572;9100153105;Current Topics in Pharmacology;journal;09724559;0.127;Q4;6;11;49;572;5;49;0.06;52;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
573;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.127;Q3;7;12;25;498;6;25;0.24;41.5;Turkey;Middle East;Hacettepe University, Faculty of Pharmacy;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
574;21716;Pharmazeutische Zeitung;journal;00317136;0.127;Q4;7;516;1405;937;19;624;0.01;1.82;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
575;19700175002;Pharmaceutical Reviews;journal;19185561;0.126;Q4;5;19;32;566;8;32;0.25;29.79;Canada;Northern America;;2009-2011;"Analytical Chemistry (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
576;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0.126;Q4;31;11;9;1260;3;9;0.33;114.55;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
577;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.125;-;31;59;161;1671;40;153;0.26;28.32;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q4)
578;19700175034;Pharmaceutical Processing;trade journal;10499156;0.125;Q3;3;50;58;78;5;47;0.09;1.56;United States;Northern America;Advantage Business Media;2009-2018;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
579;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.124;Q4;17;304;1018;5188;134;1018;0.11;17.07;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
580;22979;Journal of Applied Therapeutic Research;journal;10292659;0.124;Q4;8;8;26;169;5;26;0.14;21.13;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
581;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.123;Q4;3;20;72;311;3;65;0.06;15.55;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
582;19700174926;International Journal of Health Research;journal;15969819, 15969886;0.122;Q4;9;28;33;797;11;31;0.33;28.46;Nigeria;Africa;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
583;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.122;Q4;5;46;38;1116;3;33;0.08;24.26;Czech Republic;Eastern Europe;SOLEN S.R.O.;2009-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
584;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.121;Q4;15;133;268;2095;41;267;0.14;15.75;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
585;21100804474;European Pharmaceutical Journal;journal;24536725;0.121;Q3;8;12;21;336;4;19;0.19;28;Germany;Western Europe;de Gruyter;2016-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
586;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.121;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
587;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.121;Q4;18;6;1;539;0;1;0;89.83;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2020;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
588;144879;Toxicology International;journal;09716580;0.121;Q4;28;23;66;485;9;66;0.1;21.09;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
589;19700174925;European Pharmaceutical Review;trade journal;13608606;0.12;Q3;8;43;29;799;4;23;0.14;18.58;United Kingdom;Western Europe;Russell Publishing LLC;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4)"
590;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.119;Q4;12;92;233;1721;31;233;0.16;18.71;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
591;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.119;Q3;23;34;18;720;2;16;0.11;21.18;United States;Northern America;Elsevier Inc.;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacy (Q3)"
592;11100153314;Frontiers in Medicinal Chemistry;book series;18755763, 15742042;0.119;Q4;7;15;29;2233;3;28;0.1;148.87;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006, 2009-2010;"Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
593;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;0.119;Q4;5;0;30;0;2;30;0;0;Taiwan;Asiatic Region;Pharmaceutical Society of Republic of China;2007, 2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
594;145689;Alimentary Pharmacology and Therapeutics Symposium Series;journal;17466334;0.118;Q3;9;0;12;0;1;12;0;0;United Kingdom;Western Europe;;2005-2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
595;19700175125;Internet Journal of Pharmacology;journal;15312976;0.118;Q4;8;24;41;652;11;41;0.27;27.17;United States;Northern America;Internet Scientific Publications, LLC;2009-2011;Pharmacology (Q4)
596;19700174940;SA Pharmaceutical Journal;journal;10151362;0.118;Q4;7;163;137;1364;7;100;0.05;8.37;South Africa;Africa;Medpharm Publications;2009-2021;Pharmaceutical Science (Q4)
597;19700175108;Drug Delivery System;journal;18812732, 09135006;0.117;Q4;8;30;87;698;8;87;0.05;23.27;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
598;19200156912;EJHP Practice;trade journal;20303769, 17819989;0.117;Q3;6;73;148;718;13;102;0.09;9.84;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
599;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.116;Q4;18;24;72;825;4;72;0.02;34.38;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
600;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.116;Q3;12;18;4;632;1;4;0.25;35.11;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
601;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.115;Q4;9;11;26;215;6;26;0;19.55;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
602;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.115;Q4;10;25;95;221;7;94;0.08;8.84;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q4)
603;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.115;Q4;10;0;15;0;3;13;0.2;0;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery (Q4); Organic Chemistry (Q4)"
604;21100197929;Toxicological Research;journal;19768257, 22342753;0.115;Q4;35;11;76;356;5;76;0.07;32.36;South Korea;Asiatic Region;Koreal Association of Medical Journal Editors;2008-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
605;19700175137;Trends in Medical Research (discontinued);journal;18193587, 21516065;0.115;Q3;10;5;20;279;5;20;0.25;55.8;United States;Northern America;Academic Journals Inc.;2008-2016, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4)"
606;22358;U.S. Pharmacist;trade journal;01484818;0.115;Q4;9;136;463;2380;37;437;0.08;17.5;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
607;19700200880;Botulinum Journal;journal;17547326, 17547318;0.114;Q4;6;8;8;292;3;6;0.38;36.5;Switzerland;Western Europe;Inderscience Publishers;2009-2013, 2016;"Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
608;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148, 22123334;0.114;Q4;25;24;51;2355;19;51;0.37;98.13;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2017;"Biochemistry (medical) (Q4); Drug Discovery (Q4); Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Medicine (miscellaneous) (Q4)"
609;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.113;Q4;7;6;18;267;5;18;0.08;44.5;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
610;20543;Pharmacometrics;journal;03008533;0.113;Q4;6;23;16;309;3;16;0.19;13.43;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
611;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.112;Q4;6;40;121;147;2;118;0.02;3.68;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q4); Pharmaceutical Science (Q4)"
612;19700174924;Biomedical and Pharmacology Journal;journal;09746242;0.111;Q4;22;79;88;1261;5;88;0.06;15.96;India;Asiatic Region;Oriental Scientific Publishing Company;2009-2021;Pharmacology (Q4)
613;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.111;Q4;5;51;234;342;3;233;0.02;6.71;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
614;25196;Revista Brasileira de Toxicologia;journal;14152983;0.111;Q4;7;6;28;163;1;28;0;27.17;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
615;20628;Circular Farmaceutica;journal;00097314;0.11;Q4;3;30;120;391;1;106;0.01;13.03;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
616;19700182629;Methods in Pharmacology and Toxicology;book series;15572153, 19406053;0.11;Q4;10;0;22;0;4;21;0.18;0;United States;Northern America;Humana Press;2008, 2012, 2014-2021;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
617;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;0.11;Q4;3;1;11;31;1;11;0.09;31;Russian Federation;Eastern Europe;JSC;2009-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
618;17716;Quality Assurance Journal;journal;10991786, 10878378;0.109;Q4;9;11;47;73;11;39;0.1;6.64;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
619;21227;Pharmacy in Practice;journal;13581538;0.108;Q4;5;0;147;0;3;127;0.01;0;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Health Policy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
620;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.107;Q4;8;21;48;624;4;48;0.08;29.71;Egypt;Africa/Middle East;Faculty of Pharmacy, Assiut University;2008-2014, 2018-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
621;22887;Chinese Journal of Antibiotics;journal;10018689;0.107;Q4;11;175;555;2211;25;554;0.05;12.63;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
622;15600154705;EnvironmentAsia;journal;19061714;0.107;Q4;19;61;16;1150;2;16;0.13;18.85;Thailand;Asiatic Region;Thai Society of Higher Eduation Institutes on Environment;2009-2021;"Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
623;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.107;Q4;19;110;380;2191;28;374;0.06;19.92;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
624;19500157008;Fooyin Journal of Health Sciences;journal;18778607, 18778615;0.106;Q4;6;21;14;503;1;13;0.07;23.95;Netherlands;Western Europe;Elsevier BV;2009-2010;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
625;21243;Pharmacy Times;trade journal;00030627;0.106;Q4;8;196;674;1009;16;596;0.02;5.15;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
626;25197;Revista de Toxicologia (discontinued);journal;02127113;0.106;Q4;11;15;35;85;3;34;0.04;5.67;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
627;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.105;Q4;38;7;4;518;0;4;0;74;United States;Northern America;Hindawi Publishing Corporation;2009-2019;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
628;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.105;Q4;6;41;106;0;6;106;0.02;0;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
629;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.105;Q4;11;9;31;90;2;23;0.1;10;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
630;19700174886;Arzneimitteltherapie;journal;07236913;0.105;Q4;6;138;300;1195;11;123;0.04;8.66;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;2008-2021;"Pharmacology (nursing) (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
631;19700174922;Chinese Journal of New Drugs;journal;10033734;0.105;Q4;12;250;1020;3029;44;1020;0.04;12.12;China;Asiatic Region;Chinese Journal of New Drugs Co. Ltd.;2008-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
632;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.105;Q4;6;0;6;0;0;4;0;0;Spain;Western Europe;Fundacion Alimentacion Saludable;1996-2007;Pharmacology (Q4)
633;13000154717;Current Topics in Toxicology;journal;09728228;0.105;Q4;7;0;16;0;1;16;0.11;0;India;Asiatic Region;Research Trends;2007-2009, 2011-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
634;19700174997;ONdrugDelivery;trade journal;2049145X, 20491468;0.105;Q4;6;36;4;264;0;4;0;7.33;United Kingdom;Western Europe;Frederick Furness Publishing;2009-2020;Pharmaceutical Science (Q4)
635;19700181241;Physiology and Pharmacology;journal;17350581;0.105;Q4;12;43;46;1357;4;46;0.09;31.56;Iran;Middle East;Neuroscience Research Center;2009-2021;"Pharmacology (Q4); Physiology (Q4)"
636;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.105;Q4;9;32;94;842;2;73;0.03;26.31;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
637;145000;Signal;journal;14719967;0.105;Q4;1;0;5;0;0;4;0;0;United Kingdom;Western Europe;Adis International Ltd;2005-2007;"Drug Discovery (Q4); Oncology (Q4); Pharmacology (medical) (Q4)"
638;19700174992;European Journal of Oncology Pharmacy;journal;17833914;0.104;Q4;4;41;42;209;1;37;0.02;5.1;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2015, 2017-2019;"Oncology (Q4); Pharmacology (Q4)"
639;19700175015;Infection and Drug Resistance;journal;11786973;0.104;Q4;44;3;6;95;0;5;0;31.67;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
640;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.104;Q4;33;14;12;408;1;12;0.08;29.14;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
641;17700155411;Research Journal of Environmental Toxicology (discontinued);journal;18193420;0.104;Q4;18;34;20;861;1;20;0.05;25.32;United States;Northern America;Academic Journals Inc.;2009-2016;"Health, Toxicology and Mutagenesis (Q4); Pollution (Q4); Toxicology (Q4)"
642;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.104;Q4;14;26;47;15;9;47;0.23;0.58;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
643;86688;Acta Toxicologica;journal;17316383;0.103;Q4;7;0;21;0;7;19;0;0;Poland;Eastern Europe;Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
644;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.103;Q4;5;133;260;3149;8;256;0.03;23.68;China;Asiatic Region;Editorial office of Chinese Journal of Cancer Biotherapy;2008-2011, 2013-2016, 2018-2022;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
645;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.103;Q4;5;121;310;1818;12;310;0.04;15.02;China;Asiatic Region;China Pharmaceutical University;2007-2021;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
646;19700174889;Drug Target Insights;journal;11773928;0.103;Q4;13;0;15;0;3;15;0.2;0;Italy;Western Europe;AboutScience Srl;2008-2009, 2011-2020;"Clinical Biochemistry (Q4); Medicine (miscellaneous) (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
647;19700175049;Internet Journal of Toxicology;journal;15593916;0.103;Q4;7;21;17;540;1;17;0.06;25.71;United States;Northern America;Internet Scientific Publications, LLC;2009-2011, 2013, 2015;Toxicology (Q4)
648;23009;Journal of Clinical Research;journal;13695207;0.103;Q4;11;0;6;0;0;6;0;0;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
649;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.103;Q4;7;224;854;2585;24;854;0.02;11.54;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
650;13637;Manufacturing Chemist;trade journal;02624230;0.103;Q4;6;109;247;156;2;226;0.01;1.43;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
651;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;0.103;Q4;2;0;10;0;1;10;0.1;0;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
652;5200152604;Pharma Times;journal;00316849;0.103;Q4;12;89;230;602;18;163;0.09;6.76;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
653;19700175031;Research Journal of Pharmacology (discontinued);journal;19936019, 18159362;0.103;Q4;9;18;24;385;3;24;0.13;21.39;Pakistan;Asiatic Region;Medwell Publishing;2008-2014, 2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
654;19700181314;2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009;conference and proceedings;-;0.102;-;5;0;71;0;3;70;0.04;0;United States;Northern America;;;"Molecular Medicine; Pharmacology"
655;19700182785;Ethiopian Pharmaceutical Journal;journal;10295933;0.102;Q4;5;0;15;0;1;15;0.07;0;Ethiopia;Africa;Ethiopian Pharmaceutical Journal;2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
656;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.102;Q4;19;21;42;558;2;42;0.05;26.57;Iran;Middle East;Tabriz University of Medical Sciences;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
657;21823;Pharmacia;journal;04280296;0.102;Q4;16;11;36;343;2;36;0.04;31.18;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
658;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.102;Q4;21;10;14;618;2;3;0.13;61.8;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
659;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.102;Q4;2;0;17;0;0;11;0;0;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
660;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.101;Q4;2;0;27;0;0;24;0;0;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
661;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876, 2221285X;0.101;Q4;48;28;40;836;1;40;0.03;29.86;China;Asiatic Region;Shenyang Pharmaceutical University;2009-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
662;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.101;-;12;26;24;650;0;24;0;25;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q4)
663;19700173109;Contract Pharma;trade journal;15443469, 23806559;0.101;Q4;4;146;103;119;3;86;0.03;0.82;United States;Northern America;Contract Pharma;2009-2018;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
664;4700152278;Drugs in Context;journal;17404398, 17451981;0.101;Q4;26;0;31;0;0;26;0;0;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
665;21238;Drug Topics;journal;19378157, 00126616;0.101;Q4;8;218;796;36;7;590;0.01;0.17;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
666;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.101;Q4;3;60;275;206;2;267;0.01;3.43;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
667;5200152843;Farmaceutico Hospitales;journal;02144697;0.101;Q4;3;14;86;66;1;68;0.02;4.71;Spain;Western Europe;Ediciones Mayo S.A.;2006-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
668;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.101;Q4;1;0;30;0;1;25;0.06;0;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
669;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.101;Q4;9;0;14;0;0;14;0;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
670;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.101;Q4;10;17;16;349;0;16;0;20.53;Jordan;Middle East;The University of Jordan;2009-2021;Pharmaceutical Science (Q4)
671;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.101;Q4;6;0;20;0;1;20;0;0;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology (Q4)
672;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.101;Q4;5;11;45;204;6;44;0.15;18.55;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
673;19700174966;Pharmakeftiki;journal;22413081, 11054999;0.101;Q4;5;2;29;219;0;28;0;109.5;Greece;Western Europe;Zita Medical Managent;2008-2010, 2012-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
674;72755;Phytomedica;journal;09723293;0.101;Q4;4;0;29;0;0;29;0;0;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
675;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.101;Q4;39;0;17;0;0;17;0;0;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
676;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.1;Q4;3;41;117;144;0;96;0;3.51;France;Western Europe;Elsevier Masson s.r.l.;2005-2012;Pharmaceutical Science (Q4)
677;19700182251;Air and Waste Management Association - Harmonizing Greenhouse Gas Assessment and Reporting Processes 2009;conference and proceedings;-;0.1;-;0;0;44;0;0;42;0;0;United States;Northern America;;;"Ecology; Pollution; Toxicology; Waste Management and Disposal"
678;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.1;Q4;8;19;63;368;1;58;0;19.37;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
679;19700171709;Arhiv za Farmaciju;journal;00041963;0.1;Q4;4;34;36;828;1;36;0.03;24.35;Serbia;Eastern Europe;Farmaceutsko Drustvo Srbije;1954-1955, 2009-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
680;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.1;Q4;3;18;36;202;0;36;0;11.22;Azerbaijan;Eastern Europe;Azerbaijan Medical University;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
681;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.1;Q4;2;41;197;33;1;176;0;0.8;Germany;Western Europe;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
682;19700174996;European Life Science Journal;trade journal;20001444;0.1;Q4;1;35;86;3;1;85;0.01;0.09;Norway;Western Europe;International Business Media AB;2009-2011;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
683;21798;Farmaceutski Glasnik;journal;00148202;0.1;Q4;6;69;183;421;4;156;0.02;6.1;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
684;21867;Geneesmiddelenbulletin;journal;03044629;0.1;Q4;7;45;200;130;2;48;0.02;2.89;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
685;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.1;Q4;7;77;268;657;2;261;0.01;8.53;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
686;19700169211;Life Science Clusters;trade journal;17528119;0.1;Q4;0;11;60;0;0;55;0;0;United Kingdom;Western Europe;Avakado Ltd;2009-2010;"Biotechnology (Q4); Industrial Relations (Q4); Management of Technology and Innovation (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
687;19700175602;Next Generation Pharmaceutical;trade journal;-;0.1;Q4;1;81;109;0;1;75;0.01;0;United Kingdom;Western Europe;GDS International;2009-2011;"Drug Discovery (Q4); Marketing (Q4); Organizational Behavior and Human Resource Management (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Strategy and Management (Q4)"
688;21077;Pharmaca;journal;00316857;0.1;Q4;5;11;49;354;0;41;0;32.18;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
689;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.1;Q4;3;67;71;246;1;71;0.01;3.67;United Kingdom;Western Europe;Samedan Ltd;2009-2016, 2018-2019;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
690;5000158120;Pharmacy News;journal;1448207X;0.1;Q4;1;121;749;0;1;286;0;0;United Kingdom;Western Europe;Reed Business Publishing;2006-2009;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
691;5800207507;Side Effects of Drugs Annual;book series;03786080;0.1;Q4;6;52;156;4867;5;102;0.03;93.6;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
692;16800154712;Sp2;trade journal;1476184X;0.1;Q4;2;74;64;64;1;58;0.02;0.86;United Kingdom;Western Europe;Avakado Ltd;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
693;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.1;Q4;46;136;366;2348;149;351;0.31;17.26;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
694;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;;-;73;106;0;2639;0;0;0;24.9;United States;Northern America;American Chemical Society;2010-2021;"Biochemistry; Drug Discovery; Organic Chemistry"
695;19700174978;American Journal of Pharmacy Benefits;journal;21642494, 19454481;;-;15;56;0;911;0;0;0;16.27;United States;Northern America;Managed Care and Healthcare Communications;2010-2018;"Business and International Management; Decision Sciences (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
696;21100469670;Antibiotics;journal;20796382;;-;47;1;0;140;0;0;0;140;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010, 2012-2021;"Biochemistry; Infectious Diseases; Microbiology; Microbiology (medical); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
697;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;;-;29;9;0;296;0;0;0;32.89;United States;Northern America;Springer Science + Business Media;2010-2021;"Biomedical Engineering; Oncology; Pharmaceutical Science; Physical and Theoretical Chemistry"
698;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;;-;10;39;0;2365;0;0;0;60.64;New Zealand;Pacific Region;Libertas Academica Ltd.;2010-2018;"Medicine (miscellaneous); Pharmaceutical Science; Pharmacology"
699;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;32;75;2531;197;75;2.58;79.09;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
700;21100212330;Drug Discoveries and Therapeutics;journal;1881784X, 18817831;;-;27;52;0;0;0;0;0;0;Japan;Asiatic Region;"International Advancement Center for Medicine &amp; Health Research Co., Ltd. (IACMHR Co., Ltd.)";1997, 2010-2018, 2020;"Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
701;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;30;68;982;51;68;0.61;32.73;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
702;19700201201;EPMA Journal;journal;18785077, 18785085;;-;39;57;0;4343;0;0;0;76.19;United Kingdom;Western Europe;BioMed Central Ltd.;2010-2021;"Biochemistry (medical); Drug Discovery; Health Policy"
703;21100195303;Eurasian Journal of Analytical Chemistry (discontinued);journal;13063057;;-;16;1;0;31;0;0;0;31;Turkey;Middle East;Moment Publications;2010-2018, 2020;"Analytical Chemistry; Electrochemistry; Pharmaceutical Science; Spectroscopy"
704;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277, 09644679;;-;6;19;0;319;0;0;0;16.79;United Kingdom;Western Europe;Pharmaceutical and Healthcare Sciences Society;2010-2016, 2018-2021;"Pharmaceutical Science; Pharmacy"
705;19700176055;F1000 Biology Reports;journal;1757594X, 17404118;;-;31;88;0;2780;0;0;0;31.59;United Kingdom;Western Europe;Faculty of 1000 Ltd;2010-2013;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Immunology and Microbiology (miscellaneous) ; Neuroscience (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
706;19700174923;Farmaceutyczny Przeglad Naukowy;journal;14255073;;-;3;85;0;2153;0;0;0;25.33;Poland;Eastern Europe;Grupa Dr. A. R. Kwiecinskiego;2010-2011;Pharmaceutical Science
707;21100214102;Frontiers in Pharmacology;journal;16639812;;-;104;41;0;1928;0;0;0;47.02;Switzerland;Western Europe;Frontiers Media S.A.;2010-2021;"Pharmacology; Pharmacology (medical)"
708;19700181240;Global Journal of Pharmacology (discontinued);journal;19920075;;-;18;24;0;559;0;0;0;23.29;Pakistan;Asiatic Region;International Digital Organization for Scientific Information;2010-2014;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
709;19700188318;International Journal of Advances in Pharmaceutical Sciences (discontinued);journal;09761055;;-;11;51;0;1401;0;0;0;27.47;United States;Northern America;Advanced Research Journals;2010-2011;"Pharmaceutical Science; Physical and Theoretical Chemistry"
710;21100421502;International Journal of Biomedical Nanoscience and Nanotechnology;journal;17560802, 17560799;;-;8;14;0;894;0;0;0;63.86;Switzerland;Western Europe;Inderscience Publishers;2011;"Biomedical Engineering; Medicine (miscellaneous); Pharmaceutical Science"
711;19700200860;International Journal of Current Pharmaceutical Review and Research (discontinued);journal;0976822X;;-;14;13;0;341;0;0;0;26.23;India;Asiatic Region;Publishers, In-IJCPR;2010-2017;Pharmaceutical Science
712;19700175758;International Journal of Drug Development and Research (discontinued);journal;09759344;;-;24;121;0;2516;0;0;0;20.79;India;Asiatic Region;International Journal of Drug Development and Research;2010-2015;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
713;19700174645;International Journal of Pharmaceutical Research (discontinued);journal;09752366;;-;24;51;0;968;0;0;0;18.98;India;Asiatic Region;Advanced Scientific Research;2010-2021;"Pharmaceutical Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
714;19700200861;International Journal of Pharmaceutical Sciences;journal;09754725;;-;11;79;0;1627;0;0;0;20.59;India;Asiatic Region;R R College of Pharmacy;2010, 2012-2013;"Drug Discovery; Pharmaceutical Science"
715;19700188319;International Journal of Pharmaceutical Sciences Review and Research (discontinued);journal;0976044X;;-;33;306;0;7821;0;0;0;25.56;India;Asiatic Region;Global Research Online;2010-2016, 2020-2021;Pharmaceutical Science
716;19700188355;International Journal of Phytomedicine (discontinued);journal;09750185;;-;20;59;0;1635;0;0;0;27.71;United States;Northern America;Advanced Research Journals;2010-2016;"Complementary and Alternative Medicine; Drug Discovery"
717;19700175778;International Journal of Research in Pharmaceutical Sciences (discontinued);journal;09757538;;-;21;73;0;1518;0;0;0;20.79;India;Asiatic Region;"JK Welfare &amp; Pharmascope Foundation";2010-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
718;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;;-;44;33;60;944;18;60;0.34;28.61;Iran;Middle East;Mashhad University of Medical Sciences;2007-2021;"Biochemistry; Biophysics; Clinical Biochemistry; Drug Discovery; Immunology and Microbiology (miscellaneous) "
719;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;;-;13;34;0;790;0;0;0;23.24;Iran;Middle East;Iranian Association of Pharmaceutical Scientists;2010-2014, 2016-2021;"Bioengineering; Pharmaceutical Science"
720;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;;-;38;60;0;1214;0;0;0;20.23;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;Pharmaceutical Science
721;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;;-;29;63;0;1049;0;0;0;16.65;Netherlands;Western Europe;Wolters Kluwer Medknow Publications;2010-2021;"Complementary and Alternative Medicine; Drug Discovery"
722;19700188309;Journal of Bioanalysis and Biomedicine (discontinued);journal;1948593X;;-;11;23;0;518;0;0;0;22.52;United States;Northern America;OMICS Publishing Group;2010-2014;Pharmaceutical Science
723;19700201516;Journal of Chemical and Pharmaceutical Sciences (discontinued);journal;09742115;;-;25;69;0;1087;0;0;0;15.75;India;Asiatic Region;SPB Pharma Society;2010-2016;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Pharmaceutical Science; Pharmacology"
724;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;;-;16;16;0;697;0;0;0;43.56;United States;Northern America;IPEC-Americas;2010-2021;"Food Science; Pharmaceutical Science"
725;21100781436;Journal of Experimental Pharmacology;journal;11791454;;-;15;1;0;49;0;0;0;49;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010, 2012-2021;"Molecular Medicine; Pharmacology; Pharmacology (medical)"
726;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;26;79;305;3;78;0.04;11.73;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
727;19700200708;Journal of Global Pharma Technology (discontinued);journal;09758542;;-;17;135;0;2618;0;0;0;19.39;India;Asiatic Region;Journal of Global Pharma Technology;2010-2020;Pharmaceutical Science
728;21100881509;Journal of International Pharmaceutical Research;journal;16740440;;-;7;71;0;2011;0;0;0;28.32;China;Asiatic Region;Editorial office of Journal of International Pharmaceutical Research;2010-2011, 2013-2020;Pharmaceutical Science
729;21100241608;Journal of Nanomedicine and Nanotechnology (discontinued);journal;21577439;;-;24;3;0;70;0;0;0;23.33;United States;Northern America;OMICS Publishing Group;2010-2014;"Bioengineering; Biomedical Engineering; Medicine (miscellaneous); Pharmaceutical Science"
730;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;;-;16;29;0;763;0;0;0;26.31;United Kingdom;Western Europe;Oxford University Press;2010-2021;"Economics, Econometrics and Finance (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
731;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;;-;6;16;0;219;0;0;0;13.69;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2011, 2013-2021;"Drug Discovery; Pharmaceutical Science; Pharmacology"
732;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;;-;21;15;0;260;0;0;0;17.33;United Kingdom;Western Europe;BioMed Central Ltd.;2013-2021;"Health Policy; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
733;19700175120;Journal of Pharmaceutical Research and Health Care;journal;09753648;;-;9;48;0;767;0;0;0;15.98;India;Asiatic Region;;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
734;19700175858;Journal of Pharmacognosy and Phytotherapy (discontinued);journal;21412502;;-;22;17;0;353;0;0;0;20.76;United States;Northern America;Academic Journals Inc.;2010-2017;Drug Discovery
735;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;;-;37;15;0;346;0;0;0;23.07;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;"Pharmacology; Pharmacology (medical)"
736;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;;-;10;5;0;399;0;0;0;79.8;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010-2016, 2018;"Biochemistry; Biophysics; Cell Biology; Pharmacology"
737;21100928216;Journal of Research in Pharmacy;journal;26306344;;-;16;22;0;735;0;0;0;33.41;Turkey;Middle East;Marmara University;2019-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
738;19700175023;Journal of Toxicology;journal;16878205, 16878191;;-;39;9;0;360;0;0;0;40;Egypt;Africa/Middle East;Hindawi Limited;2010-2021;"Pharmacology; Toxicology"
739;21100244805;Journal of Vaccines and Vaccination (discontinued);journal;21577560;;-;12;12;0;491;0;0;0;40.92;United States;Northern America;OMICS Publishing Group;2010-2014;"Drug Discovery; Immunology; Immunology and Allergy; Virology"
740;19700177128;Journal of Young Pharmacists (discontinued);journal;09751505, 09751483;;-;30;83;0;1417;0;0;0;17.07;India;Asiatic Region;EManuscript Services;2010-2018, 2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
741;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;181;434;4613;146;434;0.34;25.49;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
742;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;;-;10;39;0;957;0;0;0;24.54;Netherlands;Western Europe;IOS Press BV;2010-2021;"Drug Discovery; Organic Chemistry; Plant Science"
743;19700201410;Milestones in Drug Therapy;book series;22966056;;-;5;41;0;3385;0;0;0;82.56;United States;Northern America;Springer Science + Business Media;2010-2017;"Drug Discovery; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
744;19700180522;Molecular and Cellular Toxicology;journal;20928467, 1738642X;;-;23;50;0;1499;0;0;0;29.98;Germany;Western Europe;Springer Verlag;2010-2021;"Health, Toxicology and Mutagenesis; Pathology and Forensic Medicine; Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Public Health, Environmental and Occupational Health; Toxicology"
745;19700178100;Nanotechnology, Science and Applications;journal;11778903;;-;30;17;0;1083;0;0;0;63.71;New Zealand;Pacific Region;Dove Medical Press Limited;2010-2012, 2014-2021;"Bioengineering; Biomedical Engineering; Nanoscience and Nanotechnology; Pharmaceutical Science"
746;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;2;1;0;0;1;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
747;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;;-;7;8;0;176;0;0;0;22;India;Asiatic Region;Medicinal and Aromatic Plants Association of India;2010-2019;"Complementary and Alternative Medicine; Drug Discovery"
748;21100205919;Open Drug Discovery Journal;journal;18773818;;-;9;26;0;1967;0;0;0;75.65;United Arab Emirates;Middle East;Bentham open;2010, 2014;Drug Discovery
749;19700174975;Pharmaceutical Formulation and Quality;trade journal;15312135, 19363435;;-;1;49;0;79;0;0;0;1.61;United States;Northern America;Wiley-Blackwell;2010-2012;Pharmaceutical Science
750;19700188360;Pharmaceutics;journal;19994923;;-;68;28;2;962;0;1;0;34.36;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010-2021;Pharmaceutical Science
751;19900191846;PharmacoEconomics - German Research Articles;journal;1868677X, 16123727;;-;3;9;0;239;0;0;0;26.56;New Zealand;Pacific Region;Adis Press;2010-2012;"Economics, Econometrics and Finance (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
752;19700174941;Pharmacognosy Research (discontinued);journal;09748490;;-;37;79;0;1758;0;0;0;22.25;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2019, 2021;"Drug Discovery; Pharmacology"
753;19700175580;PharmacoVigilance Review;journal;17526752;;-;2;23;0;66;0;0;0;2.87;United Kingdom;Western Europe;Euromed Communications;2010-2019;"Health Policy; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
754;19600166320;Protein and Cell;journal;16748018, 1674800X;;-;74;134;0;6271;0;0;0;46.8;China;Asiatic Region;Higher Education Press;2010-2021;"Biochemistry; Biotechnology; Cell Biology; Drug Discovery; Medicine (miscellaneous)"
755;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;21;65;2577;131;65;1.91;122.71;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
756;19700174658;Regulatory Rapporteur;trade journal;17428955;;-;6;76;0;360;0;0;0;4.74;United Kingdom;Western Europe;TOPRA;2010-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Pharmacy"
757;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences (discontinued);journal;09758585;;-;31;296;0;5803;0;0;0;19.6;India;Asiatic Region;RJPBCS;2010-2017, 2020-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
758;21100201517;RSC Drug Discovery Series;book series;20413203, 20413211;;-;10;28;0;3295;0;0;0;117.68;United Kingdom;Western Europe;Royal Society of Chemistry;2010, 2014-2021;Drug Discovery
759;21100977423;RSC Medicinal Chemistry;journal;26328682;;-;62;48;0;1878;0;0;0;39.13;United Kingdom;Western Europe;Royal Society of Chemistry;2020-2021;"Biochemistry; Drug Discovery; Molecular Medicine; Organic Chemistry; Pharmaceutical Science; Pharmacology"
760;19700201140;Systematic Reviews in Pharmacy (discontinued);journal;09758453, 09762779;;-;28;25;0;1493;0;0;0;59.72;India;Asiatic Region;EManuscript Technologies;2010-2021;Pharmaceutical Science
761;19700200821;Therapeutic Delivery;journal;20415990, 20416008;;-;52;70;0;5019;0;0;0;71.7;United Kingdom;Western Europe;Future Science;2010-2021;Pharmaceutical Science
